Amedeo Smart

Free Medical Literature Service


 

Amedeo

Diabetes

  Free Subscription

Articles published in
J Clin Endocrinol Metab
    August 2026
  1. IZUMIHARA R, Nomoto H, Chiba K, Kameda H, et al
    Relationship between Metabolic Remodeling of Pancreatic beta-cells and Pancreatic Histology in Type 2 Diabetes.
    J Clin Endocrinol Metab. 2026 Aug 5:dgag315. doi: 10.1210.
    >> Share

    July 2026
  2. REGURAM R, Shah R, Vora T, Arsene C, et al
    Insulin Pump Use and Hospital Outcomes in Adults With Type 1 Diabetes: A 2022 Nationwide Readmissions Database Analysis.
    J Clin Endocrinol Metab. 2026 Jul 30:dgag307. doi: 10.1210.
    >> Share


  3. Correction to: Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults with Prediabetes: systematic review and meta-analysis of randomized controlled trials.
    J Clin Endocrinol Metab. 2026 Jul 22:dgag275. doi: 10.1210.
    >> Share

  4. SEELY EW, Lassey SC, Palermo NE
    Approach to the patient after gestational diabetes mellitus: what's next?
    J Clin Endocrinol Metab. 2026 Jul 17:dgag233. doi: 10.1210.
    >> Share

  5. MAZHUDE T, Lopez Fanas R, Myers AK
    Racial/ethnic inequities in diabetes mellitus: a narrative review.
    J Clin Endocrinol Metab. 2026 Jul 16:dgag277. doi: 10.1210.
    >> Share

  6. TOMMERDAHL KL, Miller KR, Liu JJ, Choi YJ, et al
    Proteomic signatures of loss of glycemic control in youth-onset type 2 diabetes in the TODAY study.
    J Clin Endocrinol Metab. 2026 Jul 15:dgag281. doi: 10.1210.
    >> Share

  7. KATSUUMI G, Minamino T
    Dissecting out the unexpected effects of SGLT2 inhibitors on human aging.
    J Clin Endocrinol Metab. 2026;111:2154-2165.
    >> Share

    June 2026
  8. SATO F, Mita T, Katakami N, Okada Y, et al
    Continuous glucose monitoring-derived time in range is associated with changes in arterial stiffness in type 2 diabetes.
    J Clin Endocrinol Metab. 2026 Jun 30:dgag261. doi: 10.1210.
    >> Share

  9. COHEN A, Karmi O, Abdulhag UN, Klopstock T, et al
    Reversible Mitochondrial Iron Toxicity in Wolfram Syndrome Type 2 Monogenic Diabetes.
    J Clin Endocrinol Metab. 2026 Jun 24:dgag250. doi: 10.1210.
    >> Share

  10. LUNATI ME, Cimino V, Bernasconi D, Romano C, et al
    The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults.
    J Clin Endocrinol Metab. 2026;111:1842-1849.
    >> Share

  11. COMFORT L, Benjamin A, Brenner E, Krantz D, et al
    The need for pharmacotherapy among patients with one or more elevations on glucose tolerance test.
    J Clin Endocrinol Metab. 2026;111:1940-1948.
    >> Share

  12. IMPRODA N, Katugampola H, Cerbone M, Shah P, et al
    Clinical spectrum of extreme insulin resistance syndromes treated with rhIGF-1: A single-center experience.
    J Clin Endocrinol Metab. 2026;111:2049-2063.
    >> Share

  13. PARIKH M, Pu J, Shen J, Kramer CK, et al
    Exenatide induces an enhanced endogenous glucagon-like peptide-1 secretory response in patients receiving basal insulin.
    J Clin Endocrinol Metab. 2026;111:e1884-e1891.
    >> Share

  14. MASUDA T, Katakami N, Taya N, Miyashita K, et al
    Classification of glucose profile in Japanese patients with type 1 diabetes and its association with complications.
    J Clin Endocrinol Metab. 2026 Jun 8:dgag224. doi: 10.1210.
    >> Share

    May 2026
  15. CALDARA R, Catarinella D, Gremizzi C, Tentori S, et al
    Post-Transplant Diabetes Mellitus Requiring Insulin Identifies High-Risk Outcomes After Solid Organ Transplantation.
    J Clin Endocrinol Metab. 2026 May 26:dgag217. doi: 10.1210.
    >> Share

  16. VARALDO E, Lustenberger S, Atila C, Monnerat S, et al
    Bone turnover in arginine vasopressin deficiency: a comparative study with primary polydipsia and healthy controls.
    J Clin Endocrinol Metab. 2026;111:e1523-e1531.
    >> Share

  17. MAHADEVAN A, Vosooghi A, Arora JS, Kumar RS, et al
    GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization.
    J Clin Endocrinol Metab. 2026;111:1604-1612.
    >> Share

  18. CHACKO SR, Sharma SS, Ahmadian S, Saini J, et al
    Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2026;111:1613-1627.
    >> Share

  19. PEARSON MJ, Willency JA, Lin Y, Abadi A, et al
    Retatrutide And Lipid And Metabolite Profiles In Participants With Obesity With Or Without Type 2 Diabetes.
    J Clin Endocrinol Metab. 2026 May 14:dgag201. doi: 10.1210.
    >> Share

  20. SEAQUIST ER, Park YW, Kumar A, Alvear A, et al
    Impact of Recurrent Hypoglycemia on Brain Glucose Transport Kinetics in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2026 May 13:dgag205. doi: 10.1210.
    >> Share


  21. Correction to: "Automated insulin delivery in young children with type 1 diabetes: a systematic review and meta-analysis".
    J Clin Endocrinol Metab. 2026 May 6:dgag191. doi: 10.1210.
    >> Share

    April 2026
  22. HONDA M, Honda R, Nomura TK, Nishikado Y, et al
    Digenic HNF1A and ABCC8 Variants Provide Mechanistic Insight into Early-Onset Diabetes.
    J Clin Endocrinol Metab. 2026 Apr 23:dgag183. doi: 10.1210.
    >> Share

  23. MISKELLY MG, Lindqvist A, Jujic A, Hamilton A, et al
    HMGCR and Rosuvastatin Regulates GLP-1 Secretion and Expression-A Translational Study.
    J Clin Endocrinol Metab. 2026;111:e1343-e1355.
    >> Share

  24. SHARP LN, Colclough K, Murray Leech J, Cannon SJ, et al
    Population Prevalence, Penetrance, and Mortality for Genetically Confirmed MODY.
    J Clin Endocrinol Metab. 2026;111:e1388-e1395.
    >> Share

  25. OSHIMA M, Hara A, Toyama T, Asayama A, et al
    Polygenic risk scores and lifestyle factors predicting new onset of type 2 diabetes in the Japanese general population.
    J Clin Endocrinol Metab. 2026 Apr 16:dgag171. doi: 10.1210.
    >> Share

  26. PRAHALAD P, Zaharieva D, Maahs D
    Diabetes Technology: An Update.
    J Clin Endocrinol Metab. 2026 Apr 13:dgag164. doi: 10.1210.
    >> Share

  27. MOHSEN M, Yi TW, Faruque L, Ke C, et al
    Combination Treatment for Management of Chronic Kidney Disease and Type 2 Diabetes: A Review and Practical Guidance.
    J Clin Endocrinol Metab. 2026 Apr 13:dgag163. doi: 10.1210.
    >> Share

  28. BROSSFIELD AV, Williams KM, Kim TJ, Gjeci J, et al
    Sex- and Pubertal Stage-Specific Bone Microarchitecture and Strength in Adolescents With Type 1 Diabetes.
    J Clin Endocrinol Metab. 2026 Apr 11:dgag161. doi: 10.1210.
    >> Share

    March 2026
  29. OKTAVIAN P, Kencono Wungu CD, Amin IM, Mudjanarko SW, et al
    Automated Insulin Delivery in Young Children with Type 1 Diabetes: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2026 Mar 25:dgag133. doi: 10.1210.
    >> Share

  30. JAO J, Mukonda E, Madlala HP, Myer L, et al
    Gestational diabetes in South African women with HIV and HIV-seronegative women: Results from the ORCHID cohort.
    J Clin Endocrinol Metab. 2026 Mar 17:dgag111. doi: 10.1210.
    >> Share

  31. ATILA C, Refardt J, Christ-Crain M
    Arginine Vasopressin Deficiency and Oxytocin Deficiency in the Endocrine Clinic.
    J Clin Endocrinol Metab. 2026;111:922-937.
    >> Share

  32. ALLEN LA, Taylor PN, Carlsson A, Fraser DP, et al
    Relative maternal protection against type 1 diabetes: a combined analysis of five observational studies.
    J Clin Endocrinol Metab. 2026 Mar 10:dgag103. doi: 10.1210.
    >> Share

  33. VAZQUEZ L, Arreola EV, Nagul M, Krakoff J, et al
    Comparing Surrogate Indexes for Insulin Resistance as Predictors of Type 2 Diabetes (T2D).
    J Clin Endocrinol Metab. 2026 Mar 10:dgag101. doi: 10.1210.
    >> Share

  34. ALESI S, Mason T, Ellery SJ, Rassie K, et al
    Early pregnancy biomarkers of inflammation and metabolic regulation in polycystic ovary syndrome.
    J Clin Endocrinol Metab. 2026 Mar 9:dgag098. doi: 10.1210.
    >> Share

  35. DELLA ROSA PA, Pecco N, Calloni SF, Canini M, et al
    Multimodal MRI Neurodevelopmental Profiling in Type 1 Diabetes: Long-term Effects of MDI vs CSII Treatments.
    J Clin Endocrinol Metab. 2026 Mar 7:dgag102. doi: 10.1210.
    >> Share

    February 2026
  36. BACHA F, Saha PK, Armamento-Villareal R, Shypailo RJ, et al
    Adverse effect of obesity and dysglycemia on bone microarchitecture and strength in youth: sex-related differences.
    J Clin Endocrinol Metab. 2026 Feb 28:dgag087. doi: 10.1210.
    >> Share

  37. ZHOU X, Carrasquilla GD, Christiansen MR, Smit RAJ, et al
    Association of genetic risk and physical activity with incident type 2 diabetes.
    J Clin Endocrinol Metab. 2026 Feb 27:dgag083. doi: 10.1210.
    >> Share

  38. FLACHS MADSEN LR, Kesmodel US, Kragelund Nielsen K, Damm P, et al
    Gestational diabetes mellitus and risk of selected cancers: a Danish national register-based cohort study.
    J Clin Endocrinol Metab. 2026 Feb 25:dgag068. doi: 10.1210.
    >> Share

  39. GAO Y, Hsu V, Kil A, Arias M, et al
    Effect of Osteocalcin on Insulin Sensitivity, Insulin Secretion, and beta-cell Compensation in Mexican Americans.
    J Clin Endocrinol Metab. 2026;111:e937-e942.
    >> Share

  40. XU X, Yang H, Yu C, Zhang W, et al
    Impact of Serum Prolactin on Cognitive Function, Brain Structure and Function in Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2026 Feb 19:dgag067. doi: 10.1210.
    >> Share

  41. ORTIZ ROCHA A, Kalavalapalli S, Godinez Leiva E, Barb D, et al
    Severity of MASH Activity by Iron-Corrected MRI Predicts Insulin Resistance and Cardiometabolic Risk in Type 2 Diabetes.
    J Clin Endocrinol Metab. 2026 Feb 11:dgag042. doi: 10.1210.
    >> Share

  42. KASHER MERON M, Hornik-Lurie T, Twig G, Rotman-Pikielny P, et al
    GLP-1 receptor agonists and the risk of fragility fractures in older adults with type 2 diabetes.
    J Clin Endocrinol Metab. 2026 Feb 10:dgag056. doi: 10.1210.
    >> Share

  43. TOSUR M, Wierzchowska-McNew RA, Deutz NEP, Engelen MPKJ, et al
    Impaired Arginine, Citrulline and Glutamine Metabolism in Type 2 Diabetes: Insights from a Stable Isotope Study.
    J Clin Endocrinol Metab. 2026 Feb 7:dgag055. doi: 10.1210.
    >> Share

  44. LIU Y, Walzer D, Schmitz S, Shukla AP, et al
    Skeletal Effect of Semaglutide and Tirzepatide in Patients with Increased Risk of Fractures.
    J Clin Endocrinol Metab. 2026 Feb 7:dgag052. doi: 10.1210.
    >> Share


  45. Correction to: "Children With Pancreatic Hypoplasia Experience Poor Weight Gain and Labile Diabetes but Low Incidence of DKA".
    J Clin Endocrinol Metab. 2026 Feb 6:dgag013. doi: 10.1210.
    >> Share

  46. SCIFRES CM, Sinha A, Orris S, Costacou T, et al
    Metabolic outcomes at 12 months postpartum among individuals with glucose intolerance in pregnancy.
    J Clin Endocrinol Metab. 2026 Feb 2:dgag035. doi: 10.1210.
    >> Share

    January 2026
  47. RAMA CHANDRAN S, Koh Shimin J, Liu C, Xin Yu Lee I, et al
    Relationship between continuous glucose monitoring and corneal neuropathy in type 2 diabetes.
    J Clin Endocrinol Metab. 2026 Jan 28:dgag030. doi: 10.1210.
    >> Share

  48. KUSINSKI LC, Liu Z, Dib S, Rogers R, et al
    Association Between Polycystic Ovary Syndrome and Pregnancy Outcomes in GDM: A Secondary Analysis of the DiGest Trial.
    J Clin Endocrinol Metab. 2026 Jan 28:dgag026. doi: 10.1210.
    >> Share


  49. Correction to: "Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome".
    J Clin Endocrinol Metab. 2026;111:e646.
    >> Share

  50. VANLAER Y, Minschart C, Reyns F, Myngheer N, et al
    Treatment adherence and satisfaction of a mobile-based lifestyle intervention in women with prior gestational diabetes.
    J Clin Endocrinol Metab. 2026 Jan 21:dgag019. doi: 10.1210.
    >> Share

  51. CAO S, Cao S
    Hyperglycemic Hypernatremic Hypertonic State: A Predominant HHS Subtype and Its Clinical and Diagnostic Features.
    J Clin Endocrinol Metab. 2026;111:e406-e413.
    >> Share

  52. PRAHALAD P, Ding VY, Zaharieva DP, Addala A, et al
    Sustained HbA1c Improvements Over 36 Months in Youth in the Teamwork, Targets, Technology, and Tight Control (4T) Study.
    J Clin Endocrinol Metab. 2026;111:418-426.
    >> Share

  53. HABTEWOLD TD, Biedrzycki RJ, Wijesiriwardhana P, Asefa NG, et al
    Association of prenatal glycemic marker cumulative exposure with placental DNA methylation change.
    J Clin Endocrinol Metab. 2026 Jan 8:dgag006. doi: 10.1210.
    >> Share

    December 2025
  54. OPPENHEIMER KR, Himelhoch NT, McCullough ME, Bowden TL, et al
    Approach to the Patient - Mitochondrial Diabetes: Contemporary Cases and Precision Medicine Approach.
    J Clin Endocrinol Metab. 2025 Dec 31:dgaf698. doi: 10.1210.
    >> Share

  55. GOSMANOV AR
    Approach to the Patient with Type 2 Diabetes Treated with SGLT-2 Inhibitor: Art of Effective and Safe Prescription.
    J Clin Endocrinol Metab. 2025 Dec 23:dgaf690. doi: 10.1210.
    >> Share

  56. LIU L, Mohan S, Wu L
    GLP-1 Receptor Agonists and Non-Arteritic Anterior Ischemic Optic Neuropathy: What an Endocrinologist Needs to Know.
    J Clin Endocrinol Metab. 2025;111:e308-e313.
    >> Share

  57. SWARTZ AZ, Wood K, Farber-Eger E, Petty A, et al
    Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases.
    J Clin Endocrinol Metab. 2025;111:e49-e57.
    >> Share

  58. LI S, Liu J, Yang C, Jin Y, et al
    Impaired Glucagon Suppression Accompanied by Liver Fat Accumulation Mediated Worse Blood Glucose Control in Patients With T2D.
    J Clin Endocrinol Metab. 2025;111:180-198.
    >> Share

  59. BROGAN RJ, Rooyackers O, Phillips BE, Twelkmeyer B, et al
    Biomarkers of Insulin Resistance and Their Performance as Predictors of Treatment Response in Overweight Adults.
    J Clin Endocrinol Metab. 2025;111:244-255.
    >> Share

  60. DI GIUSEPPE G, Gliozzo G, Ciccarelli G, Carciero L, et al
    Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired beta Cell Function in Humans.
    J Clin Endocrinol Metab. 2025;111:e240-e246.
    >> Share

  61. RAETS L, Van Hoorenbeeck K, Maes T, Lee D, et al
    Women With Higher GCT Levels but NGT Have a Similarly High Risk for Glucose Intolerance Postpartum as Women With GDM.
    J Clin Endocrinol Metab. 2025;111:e281-e291.
    >> Share

  62. RAHMAN MH, Arian A, Konda S, McGuinn LA, et al
    Predicting Incident Type 2 Diabetes Using Wearable Activity and Polygenic Risk: A Survival-Modeling Study in All of Us.
    J Clin Endocrinol Metab. 2025 Dec 15:dgaf673. doi: 10.1210.
    >> Share

  63. CHEN J, Wu Y, Li F, Guo Q, et al
    Causal effect of type 1 diabetes on juvenile idiopathic arthritis and the mediating role of CD8+ natural killer T cells.
    J Clin Endocrinol Metab. 2025 Dec 15:dgaf664. doi: 10.1210.
    >> Share

  64. SOJAKKA SMITH E, Franzen A, Pihlsgard M, M Nilsson P, et al
    Nocturnal melatonin secretion and risk of type 2 diabetes: a prospective cohort study.
    J Clin Endocrinol Metab. 2025 Dec 13:dgaf667. doi: 10.1210.
    >> Share

  65. TANABE H, Shimajiri Y, Shiroma K, Higa M, et al
    Unequal distribution of plasma glucagon levels among clustering-based diabetes subtypes: a Japanese cohort.
    J Clin Endocrinol Metab. 2025 Dec 13:dgaf654. doi: 10.1210.
    >> Share

  66. NIELSEN SW, Gilliam-Vigh H, Jorsal T, Wahlgren CD, et al
    Distribution of Somatostatin and its Receptors in the Intestinal Tract in Healthy and in Patients with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 Dec 11:dgaf648. doi: 10.1210.
    >> Share

    November 2025
  67. ODE KL, Imai Y, Norris AW
    Approach to the Patient with Pancreatogenic Diabetes.
    J Clin Endocrinol Metab. 2025 Nov 18:dgaf623. doi: 10.1210.
    >> Share

  68. KONGARA T, Carruth A, Bhat P, Virostko J, et al
    Determinants of Pancreatic Size and Fat Content in the UK Biobank: Influence of Race, Genetic Variants, and Risk Factors.
    J Clin Endocrinol Metab. 2025;110:e3945-e3951.
    >> Share

  69. RAMIREZ-LUZURIAGA MJ, Vazquez Arreola E, Hanson RL, Knowler WC, et al
    Familial Associations of Metabolic Syndrome and Its Interrelated Traits in Southwestern Indigenous Americans.
    J Clin Endocrinol Metab. 2025;110:e3962-e3971.
    >> Share

  70. FERMIN-MARTINEZ CA, Bello-Chavolla OY, Paz-Cabrera CD, Ramirez-Garcia D, et al
    Prediabetes and Risk of All-Cause and Cause-Specific Mortality: A Prospective Study of 114?062 Adults in Mexico City.
    J Clin Endocrinol Metab. 2025;110:3451-3460.
    >> Share

  71. CHANG S, Pedersen L, Skakkebaek A, Berglund A, et al
    Metabolism and type 2 diabetes across life stages in Klinefelter syndrome: a population-based cohort study.
    J Clin Endocrinol Metab. 2025 Nov 15:dgaf619. doi: 10.1210.
    >> Share

  72. DI CANDIA F, Rosanio FM, Franceschi R, Fierro A, et al
    Glucometabolic control and Anti-Transglutaminase Antibodies at Celiac Disease onset in Type 1 Diabetes youth.
    J Clin Endocrinol Metab. 2025 Nov 4:dgaf604. doi: 10.1210.
    >> Share

  73. PRASAD TN, Pal R, Bhadada SK, Ram S, et al
    Interim Effects of Zoledronate, Denosumab, or Teriparatide on Bone Microarchitecture in Type 2 Diabetes: A Pilot Trial.
    J Clin Endocrinol Metab. 2025 Nov 3:dgaf589. doi: 10.1210.
    >> Share

    October 2025
  74. KONTOLA H, Crisostomo L, Loyttyniemi E, Koskenniemi JJ, et al
    Altered Glucagon Response to Oral Glucose in Individuals at Different Stages of Type 1 Diabetes Development.
    J Clin Endocrinol Metab. 2025 Oct 31:dgaf601. doi: 10.1210.
    >> Share

  75. CARRY PM, Kim S, Zwick NL, Buckner T, et al
    Increased Levels of the Vitamin D Metabolite Ratio are Protective Against Progression from Islet Autoimmunity to T1D.
    J Clin Endocrinol Metab. 2025 Oct 30:dgaf578. doi: 10.1210.
    >> Share

  76. LIANG X, Han H, Shen X, Williams PL, et al
    Hair mercury levels, serum n-3 fatty acids, and pregnancy glucose outcomes among women from a fertility center.
    J Clin Endocrinol Metab. 2025 Oct 29:dgaf594. doi: 10.1210.
    >> Share

  77. LINGVAY I, Bache JK, Desouza CV, Fragao-Marques M, et al
    Efficacy and Hypoglycemia Profile of Once-weekly Insulin Icodec vs Once-daily Comparators Across Demographic Subgroups.
    J Clin Endocrinol Metab. 2025;110:e3596-e3606.
    >> Share

  78. THANARAJ TA, Abu-Farha M, Albatineh AN, Channanath A, et al
    Effect of Ethnicity on the Relationship Between Telomere Length and Metabolic Markers in Kuwait.
    J Clin Endocrinol Metab. 2025;110:e3656-e3664.
    >> Share

  79. KAGISAKI T, Baden MY, Oyama A, Noguchi M, et al
    Impact of Weight Change on Type 2 Diabetes Risk: A Prospective Study in a Japanese Population.
    J Clin Endocrinol Metab. 2025 Oct 8:dgaf558. doi: 10.1210.
    >> Share

  80. LI Y, Zhang S, Lai Y, Wu P, et al
    Association of urinary copper and gestational diabetes mellitus: role of epigenome-wide DNA methylation and proteomics.
    J Clin Endocrinol Metab. 2025 Oct 6:dgaf555. doi: 10.1210.
    >> Share

  81. CHEN NC, Shah VN, McQueen RB
    Time in Range and Incident Diabetic Retinopathy: Clinical and Economic Evidence from Real-World Type 1 Diabetes Care.
    J Clin Endocrinol Metab. 2025 Oct 4:dgaf544. doi: 10.1210.
    >> Share

    September 2025
  82. DENSON AM, Rodriguez KE, Letourneau-Freiberg LR, Kandasamy B, et al
    Children with Pancreatic Hypoplasia Experience Poor Weight Gain and Labile Diabetes but Low Incidence of DKA.
    J Clin Endocrinol Metab. 2025 Sep 27:dgaf473. doi: 10.1210.
    >> Share

  83. SCHILLER T, Gabay L, Barak O, Kirzhner A, et al
    An oral glucose tolerance test in pregnancy can serve as a valuable predictor for future diabetes.
    J Clin Endocrinol Metab. 2025 Sep 26:dgaf534. doi: 10.1210.
    >> Share

  84. HOLLIDAY MW JR, Navaneethan SD
    Impact of SGLT2 inhibitors on glomerular filtration in type 1 diabetes.
    J Clin Endocrinol Metab. 2025 Sep 25:dgaf535. doi: 10.1210.
    >> Share

  85. ZHOU R, Jiajue R, Ni X, Pang Q, et al
    Glucose Metabolic Abnormalities and Their Interaction With Defective Phosphate Homeostasis in Tumor-induced Osteomalacia.
    J Clin Endocrinol Metab. 2025;110:2869-2878.
    >> Share

  86. LAI KZH, Harris SB, Retnakaran R, Hanley AJG, et al
    Longitudinal Association of Statin Treatment With Insulin Sensitivity and Beta-Cell Function in the PROMISE Cohort.
    J Clin Endocrinol Metab. 2025;110:e3442-e3452.
    >> Share

  87. MACLEOD SR, Tich JN, Marvald J, Zhang YV, et al
    The Influence of Social Vulnerability and Race on Diabetes Control.
    J Clin Endocrinol Metab. 2025 Sep 6:dgaf502. doi: 10.1210.
    >> Share


  88. Correction to: "Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline".
    J Clin Endocrinol Metab. 2025 Sep 3:dgaf494. doi: 10.1210.
    >> Share

    August 2025
  89. CHUBB SAP, Davis WA, Davis TME
    Effects of subclinical hypothyroidism on nephropathy complicating type 2 diabetes: The Fremantle Diabetes Study Phase II.
    J Clin Endocrinol Metab. 2025 Aug 29:dgaf485. doi: 10.1210.
    >> Share

  90. HANSEN JV, Mathiesen DS, Christensen MB, Jorgensen NR, et al
    The separate and combined effects of GIP, GLP-1 and GLP-2 on markers of bone turnover in type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Aug 29:dgaf482. doi: 10.1210.
    >> Share


  91. Correction to: "The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study".
    J Clin Endocrinol Metab. 2025 Aug 26:dgaf471. doi: 10.1210.
    >> Share

  92. YOSHIJI S, Hasebe M, Tanaka D, Shimizu M, et al
    Genetic and Clinical Characteristics of Monogenic Diabetes in Japan: A Nationwide Study by the Japan Diabetes Society.
    J Clin Endocrinol Metab. 2025 Aug 25:dgaf478. doi: 10.1210.
    >> Share

  93. BASU A
    Intensifying early diabetes education in youths with newly diagnosed type 1 diabetes for sustained glycemic outcomes.
    J Clin Endocrinol Metab. 2025 Aug 18:dgaf470. doi: 10.1210.
    >> Share

  94. LIN YT, Sayols-Baixeras S, Graells T, Dekkers KF, et al
    Identification of gut microbiome signatures and metabolites associated with albuminuria in type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Aug 14:dgaf453. doi: 10.1210.
    >> Share

  95. YANG Y, Wang JH, Wang HA, Zhang TP, et al
    Blood plasma proteome-wide association study implicates new proteins in type 2 diabetes mellitus pathogenesis.
    J Clin Endocrinol Metab. 2025 Aug 12:dgaf462. doi: 10.1210.
    >> Share

  96. SEVILLA-GONZALEZ M, Hanson PA, Islam J, Hsu S, et al
    Compartment-Specific Metabolic Alterations to Insulin Reflect Adiposity-Driven Variation and Predict Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 Aug 11:dgaf454. doi: 10.1210.
    >> Share

  97. DEL PRATO S, Bonadonna RC
    Glucagon: The Arab Phoenix of the Complex Pathophysiology of Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 Aug 11:dgaf421. doi: 10.1210.
    >> Share

  98. IGUDESMAN D, Nally LM, Grimshaw AA, Gunderson CG, et al
    Dietary patterns for weight and glycemic management in persons with type 1 diabetes: a meta-analysis of clinical trials.
    J Clin Endocrinol Metab. 2025 Aug 7:dgaf448. doi: 10.1210.
    >> Share


  99. Correction to: "A Systematic Review Supporting the Clinical Practice Guidelines on the Management of Preexisting Diabetes and Pregnancy".
    J Clin Endocrinol Metab. 2025 Aug 7:dgaf441. doi: 10.1210.
    >> Share

  100. MOHAN S, Christie HE, Laurenti MC, Egan AM, et al
    Abnormal Glucagon Secretion Contributes to a Longitudinal Decline in Glucose Tolerance.
    J Clin Endocrinol Metab. 2025;110:e2956-e2965.
    >> Share

  101. GAMAGE IL, Barmanray RD, Kyi M, Colman PG, et al
    Early electronic specialist-led diabetes care improves post-discharge glycaemia: the STOIC-D Surgery follow-up cohort.
    J Clin Endocrinol Metab. 2025 Aug 1:dgaf440. doi: 10.1210.
    >> Share

  102. HASEBE M, Su CY
    Letter to the Editor from Hasebe and Su: "Diabetes Progression and Its Impact on Kidney Cancer Risk: Insights From a Longitudinal Korean Cohort Study".
    J Clin Endocrinol Metab. 2025 Aug 1:dgaf438. doi: 10.1210.
    >> Share

  103. MYERS R, Yildiz M, Nuri Ozbek M, Manzoor J, et al
    Children with diabetes and at least one non-autoimmune feature should be considered for monogenic diabetes testing.
    J Clin Endocrinol Metab. 2025 Aug 1:dgaf430. doi: 10.1210.
    >> Share

    July 2025
  104. YAN Y, Miao J, Sun Y
    Letter to the Editor from Yan et al.:A Low-Intensity Nutrition Intervention Targeting Triglycerides in Gestational Diabetes: A Feasibility RCT.
    J Clin Endocrinol Metab. 2025 Jul 23:dgaf413. doi: 10.1210.
    >> Share

  105. RODRIGUEZ GONZALEZ A, Harrison C, Hewitt B, Mejier JL, et al
    Feasibility, Acceptability, and Validity of Home Continuous Glucose Monitoring-Based Oral Glucose Tolerance Test in Youth.
    J Clin Endocrinol Metab. 2025;110:e2510-e2516.
    >> Share

  106. KHORASHAD BS, Kaabi O, Gardner MD, Getahun D, et al
    Prevalence of Psychiatric Comorbidities in Females With Classic Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2025;110:e2562-e2569.
    >> Share

  107. KRAGELUND NIELSEN K, Dahl-Petersen IK, Jensen DM, Damm P, et al
    Effectiveness of a Family-based Health Promotion Intervention for Women With Prior GDM: The Face-It RCT.
    J Clin Endocrinol Metab. 2025;110:e2456-e2470.
    >> Share

  108. TILLMAN JB, Beck RW, Polonsky WH, Calhoun P, et al
    Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis.
    J Clin Endocrinol Metab. 2025;110:2134-2146.
    >> Share

  109. LAHOTI A, Haque MR, Bianco ME, Chaudhary A, et al
    Trends of Diabetes in Youth (TrenDY) during COVID-19 across the United States.
    J Clin Endocrinol Metab. 2025 Jul 14:dgaf395. doi: 10.1210.
    >> Share

  110. GURUNG RL, Zheng H, Tan JLI, Liu S, et al
    Response to Letter to the Editor from Hasebe and Su: "Plasma Proteins Predict Kidney Function Trajectories in Type 2 Diabetes".
    J Clin Endocrinol Metab. 2025 Jul 14:dgaf406. doi: 10.1210.
    >> Share

  111. HASEBE M, Su CY
    Letter to the Editor from Hasebe and Su: "Plasma Proteins Predict Kidney Function Trajectories in Type 2 Diabetes".
    J Clin Endocrinol Metab. 2025 Jul 14:dgaf405. doi: 10.1210.
    >> Share

  112. WYCKOFF JA, Lapolla A, Asias-Dinh BD, Barbour LA, et al
    Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2025 Jul 13:dgaf288. doi: 10.1210.
    >> Share

  113. AL NOFAL A, Benkhadra K, Abbas A, Nduwimana MJ, et al
    A Systematic Review Supporting the Clinical Practice Guidelines on the Management of Preexisting Diabetes and Pregnancy.
    J Clin Endocrinol Metab. 2025 Jul 13:dgaf289. doi: 10.1210.
    >> Share

  114. STECK AK, Parikh HM, Triolo TM, Ferrat L, et al
    Genetic Risk and Transition through Preclinical Stages of Type 1 Diabetes.
    J Clin Endocrinol Metab. 2025 Jul 9:dgaf392. doi: 10.1210.
    >> Share

  115. MICHELS AW, Brusko TM, Evans-Molina C, Homann D, et al
    Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific Statement.
    J Clin Endocrinol Metab. 2025 Jul 9:dgaf267. doi: 10.1210.
    >> Share

    June 2025
  116. ASUZU P, Aliye N, Stentz F, Wan J, et al
    Plasma Sphingolipids in Relation to Glycemia and Glucose Tolerance in People Without Diabetes.
    J Clin Endocrinol Metab. 2025 Jun 26:dgaf378. doi: 10.1210.
    >> Share

  117. RELAN S, Alarcon G, Guffey D, Minard CG, et al
    Maturity-Onset Diabetes of the Young (MODY) in a Racially/Ethnically Diverse Pediatric Population.
    J Clin Endocrinol Metab. 2025 Jun 24:dgaf360. doi: 10.1210.
    >> Share

  118. FU Q, Dai H, Wang J, Liu L, et al
    Multidimensional Pancreatic Islet beta-cell Function (PIF) Assessment Improves Predictive Effect of Diabetes Risk Scores.
    J Clin Endocrinol Metab. 2025 Jun 23:dgaf372. doi: 10.1210.
    >> Share

  119. SUN D, van Greevenbroek MMJ, Scheijen JLJM, Kelly J, et al
    Methylglyoxal Mediates the Association Between 2-Hour Plasma Glucose and HbA1c With Inflammation: The Maastricht Study.
    J Clin Endocrinol Metab. 2025;110:2047-2054.
    >> Share

  120. HE JH, Bennett WL, Ma J, Oyeka CP, et al
    Sex Hormones Mediate Intensive Lifestyle Intervention-Induced Bone Mineral Density Changes: Look AHEAD Sex Hormone Study.
    J Clin Endocrinol Metab. 2025 Jun 17:dgaf359. doi: 10.1210.
    >> Share

  121. BLAAK EE
    Precision approaches towards diabetes prevention: towards a clustering approach with more phenotypical granularity.
    J Clin Endocrinol Metab. 2025 Jun 13:dgaf341. doi: 10.1210.
    >> Share

  122. MAYA J, Schulte CCM, Hsu S, James K, et al
    Gestational Glucose Intolerance and Risk of Obesity in Childhood and Adolescence.
    J Clin Endocrinol Metab. 2025 Jun 13:dgaf345. doi: 10.1210.
    >> Share

  123. STAFFORD JM, Casanova R, Jaeger BC, Demesie Y, et al
    Prediabetes subgroups, type 2 diabetes risk, and differential effects of preventive interventions.
    J Clin Endocrinol Metab. 2025 Jun 11:dgaf350. doi: 10.1210.
    >> Share

  124. ZHOU X, Zheng W, Kong W, Zhang J, et al
    Glucose Parameters, Inflammation Markers, and Gut Microbiota Changes of Gut Microbiome-Targeted Therapies in Type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Clin Endocrinol Metab. 2025 Jun 9:dgaf340. doi: 10.1210.
    >> Share

  125. MUNOZ-PARDEZA J, Gracia-Marco L, Lopez-Gil JF, Hormazabal-Aguayo I, et al
    The role of muscular fitness on bone mineral content and areal bone mineral density in youth with type 1 diabetes.
    J Clin Endocrinol Metab. 2025 Jun 5:dgaf328. doi: 10.1210.
    >> Share

  126. COPETTI M, Menzaghi C, Trischitta V
    Predicting the effect of preventive treatment of type 2 diabetes. A further step towards precision medicine.
    J Clin Endocrinol Metab. 2025 Jun 4:dgaf327. doi: 10.1210.
    >> Share

  127. LAI SW
    Letter to the Editor from Lai: The beneficial effects of sodium-glucose cotransporter 2 inhibitors on anemia in type 2 diabetes-a real world study.
    J Clin Endocrinol Metab. 2025 Jun 4:dgaf325. doi: 10.1210.
    >> Share

  128. YU J, Kim B, Han K, Kim MK, et al
    Diabetes Progression and Its Impact on Kidney Cancer Risk: Insights From a Longitudinal Korean Cohort Study.
    J Clin Endocrinol Metab. 2025 Jun 3:dgaf249. doi: 10.1210.
    >> Share

    May 2025
  129. GOWER BA, Yurchishin ML, Goss AM, Knight J, et al
    Beneficial Effects of Carbohydrate Restriction in Type 2 Diabetes Can Be Traced to Changes in Hepatic Metabolism.
    J Clin Endocrinol Metab. 2025 May 31:dgaf324. doi: 10.1210.
    >> Share

  130. FRANK RC, Shim B, Lo T, Pandya D, et al
    Pancreatic Cancer Screening in New-Onset and Deteriorating Diabetes: Preliminary Results from the PANDOME Study.
    J Clin Endocrinol Metab. 2025 May 29:dgaf319. doi: 10.1210.
    >> Share

  131. XU B, Yang X, Ma Y, Jiang Y, et al
    Association Between Free Triiodothyronine and Diabetic Peripheral Neuropathy in Euthyroid Patients With Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 May 27:dgaf304. doi: 10.1210.
    >> Share

  132. JACK GA, Avenatti E, Kashyap SR, Sadhu AR, et al
    Overcoming Disparities in Using SGLT2 Inhibitors for Cardiorenal Protection in Persons With and Without Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 May 27:dgaf301. doi: 10.1210.
    >> Share

  133. YANG X, Zhao X, Jiang Y
    Letter to the Editor From Yang et al: "Cognitive Risk Stratification Score in Middle-aged and Older Adults With Type 2 Diabetes: A Cross-Sectional Study".
    J Clin Endocrinol Metab. 2025 May 24:dgaf307. doi: 10.1210.
    >> Share

  134. OYEKA CP, He JH, Ma J, Michos ED, et al
    Role of Sex Hormones in Mediating Adiposity Changes from Weight Loss in People with Type 2 Diabetes: Look AHEAD Sex Hormone Study.
    J Clin Endocrinol Metab. 2025 May 20:dgaf287. doi: 10.1210.
    >> Share

  135. VAIZOGLU RD, Erdem B, Gul M, Acar C, et al
    Investigation of Fibrillar Aggregates Formed by Pathogenic Pre-pro-vasopressin Mutants that Cause ADNDI.
    J Clin Endocrinol Metab. 2025;110:1577-1586.
    >> Share

  136. BIAGETTI B, Cordero Asanza E, Perez-Lopez C, Araujo-Castro M, et al
    Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter Study.
    J Clin Endocrinol Metab. 2025;110:e1811-e1820.
    >> Share

  137. LU X, Zhu X, Li G, Wu L, et al
    Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity.
    J Clin Endocrinol Metab. 2025;110:e1845-e1855.
    >> Share

  138. TATSUKAWA Y, Sposto R, Yamada M, Ohishi W, et al
    Relationship Between Radiation Dose and Markers of Insulin Resistance and Inflammation in Atomic Bomb Survivors.
    J Clin Endocrinol Metab. 2025;110:e1943-e1950.
    >> Share

  139. POHLMAN N, Patel PN, Essien UR, Tang JJ, et al
    Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome Era.
    J Clin Endocrinol Metab. 2025 May 19:dgaf295. doi: 10.1210.
    >> Share

  140. LIU K, Clarke GS, Grieger JA
    A low-intensity nutrition intervention targeting triglycerides in gestational diabetes: a feasibility RCT.
    J Clin Endocrinol Metab. 2025 May 16:dgaf291. doi: 10.1210.
    >> Share

  141. LIU JJ, Liu S, Gurung RL, Lee J, et al
    Urine choline oxidation metabolites predict chronic kidney disease progression in patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2025 May 13:dgaf281. doi: 10.1210.
    >> Share

  142. DE MEULEMEESTER J, Valgaerts L, Massa G, Gies I, et al
    Real-world Glycemic and Person-Reported Outcomes after Tandem Control-IQ initiation in Children with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2025 May 7:dgaf265. doi: 10.1210.
    >> Share

    April 2025
  143. WANG L, Lin H, Zhao Z, Chen L, et al
    Regional Brain Structure Alterations in Diabetes but Not Prediabetes: the Shanghai Changfeng Study.
    J Clin Endocrinol Metab. 2025 Apr 30:dgaf248. doi: 10.1210.
    >> Share

  144. GOEDECKE JH, Kufe CN, Masemola M, Lichaba M, et al
    SHBG, testosterone and type 2 diabetes risk in middle-aged African women: exploring the impact of HIV and menopause.
    J Clin Endocrinol Metab. 2025 Apr 28:dgaf256. doi: 10.1210.
    >> Share

  145. JAEGER B, Casanova R, Demesie Y, Stafford J, et al
    Development and validation of a diabetes risk prediction model with individualized preventive intervention effects.
    J Clin Endocrinol Metab. 2025 Apr 23:dgaf250. doi: 10.1210.
    >> Share

  146. BRANDT IAG, Vestergaard P, Harslof T, Juhl CB, et al
    Association between Muscle status and Bone Size, Density, and Strength in Type 1 Diabetes: A Cross-Sectional Study.
    J Clin Endocrinol Metab. 2025 Apr 23:dgaf245. doi: 10.1210.
    >> Share

  147. KANG F, Zhang Z, Fu H, Sun J, et al
    beta-Cell Dedifferentiation in HOMA-betalow and HOMA-betahigh Subjects.
    J Clin Endocrinol Metab. 2025;110:e1430-e1438.
    >> Share

  148. HSU JC, Huang KC, Lin TT, Lee JK, et al
    Epicardial Adipose Tissue Is Associated With Geometry Alteration and Diastolic Dysfunction in Prediabetic Cardiomyopathy.
    J Clin Endocrinol Metab. 2025;110:1478-1487.
    >> Share

  149. GLAROS SB, Dixon SD, Malandrino N, Davis FS, et al
    Navigating transition to adult care in youth-onset type 2 diabetes: Facilitators, Attitudes, Barriers, and Behaviors.
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf239. doi: 10.1210.
    >> Share

  150. SU W, Yang Y, Cheng J, Dong N, et al
    The microbial regulation spectrum of metformin in patients with type 2 diabetes: An individual-based meta-analysis of 1431 participants.
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf238. doi: 10.1210.
    >> Share

  151. CHEN C, Yu L, Lan MS
    Modulation of Functional Activity of INS-VNTR Class I Haplotype Derived from Type 1 Diabetic Patients.
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf243. doi: 10.1210.
    >> Share

  152. ZHANG J, Tam WWS, Lu J, Chen J, et al
    Response to Letter to the Editor from Bai and Zhang: "Cognitive Risk Stratification Score in Middle-aged and Older Adults with Type 2 Diabetes: A Cross-Sectional Study.".
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf241. doi: 10.1210.
    >> Share

  153. BAI Y, Zhang F
    Letter to the Editor from Bai and Zhang: "Cognitive Risk Stratification Score in Middle-aged and Older Adults With Type 2 Diabetes: A Cross-Sectional Study.".
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf240. doi: 10.1210.
    >> Share

  154. DEUTSCH AJ, Udler MS
    Phenotypic and genetic diversity in diabetes across populations.
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf234. doi: 10.1210.
    >> Share


  155. Correction to: "Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) Trial".
    J Clin Endocrinol Metab. 2025 Apr 11:dgaf205. doi: 10.1210.
    >> Share

  156. KVIST AV, Frost M, Burden AM, Vestergaard P, et al
    Direct healthcare cost of fractures in patients with type 1 diabetes: a population-based cohort study in Denmark.
    J Clin Endocrinol Metab. 2025 Apr 10:dgaf199. doi: 10.1210.
    >> Share

  157. FALCETTA P, Zilich R, Baccetti F, Baronti W, et al
    Treatment intensification strategies and metabolic outcomes in individuals with type 2 diabetes on GLP-1 RA therapy.
    J Clin Endocrinol Metab. 2025 Apr 9:dgaf229. doi: 10.1210.
    >> Share

  158. LU W, Shen D, Qiu S
    Association between visit-to-visit glucose variability and brain morphology and cognitive function in type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Apr 8:dgaf228. doi: 10.1210.
    >> Share

  159. TELES BSBS, Ramalho SHR, Bittencourt MS, Bensenor IM, et al
    Plasma levels of small HDL particles are associated with coronary atherosclerosis progression in adults with diabetes.
    J Clin Endocrinol Metab. 2025 Apr 3:dgaf215. doi: 10.1210.
    >> Share

  160. DIXON SB
    Diabetes risk in young survivors of childhood cancer: a need for prevention and survivor-specific treatment strategies.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf202. doi: 10.1210.
    >> Share

  161. LEICHTER SB, Felton JL, Rasmussen CG, Rizzuto P, et al
    Establishing Screening Programs for Presymptomatic Type 1 Diabetes: Practical Guidance for Diabetes Care Providers.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf194. doi: 10.1210.
    >> Share

  162. HUANG B, Kao YW, Yen KC, Chen SW, et al
    Effect of Initial eGFR and Albuminuria Changes on Clinical Outcomes in People With Diabetes Receiving SGLT2 Inhibitors.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf133. doi: 10.1210.
    >> Share

  163. MONTASER E, Abad SE, Shah VN
    Changes in A1C versus GMI Across Glycemic Categories in Clinical Trials of Type 1 Diabetes.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf211. doi: 10.1210.
    >> Share

  164. KU EJ, Lee J, Yoo WS, Bae J, et al
    Long-Term Non-skeletal Complications in Patients with Thyroid Cancer and Hypoparathyroidism Post-total Thyroidectomy.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf213. doi: 10.1210.
    >> Share

    March 2025
  165. THURBER EG, Lan Z, Turchin A
    Telemedicine Visit Use and Glycemic Control in Patients with Diabetes.
    J Clin Endocrinol Metab. 2025 Mar 26:dgaf177. doi: 10.1210.
    >> Share

  166. STEINMETZ T, Goldman S, Kagan KBT, Bielopolski D, et al
    The beneficial effects of sodium-glucose cotransporter 2 inhibitors on anemia in type 2 diabetes-a real world study.
    J Clin Endocrinol Metab. 2025 Mar 22:dgaf184. doi: 10.1210.
    >> Share

  167. GALINDO RJ, Moazzami B, Gerges A, Flores I, et al
    Continuous glucose monitoring improves detection of glycemic excursions in hemodialysis patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Mar 22:dgaf187. doi: 10.1210.
    >> Share

  168. ONENGUT-GUMUSCU S, Concannon P, Akolkar B, Erlich HA, et al
    The Type 1 Diabetes Genetics Consortium (T1DGC).
    J Clin Endocrinol Metab. 2025 Mar 21:dgaf181. doi: 10.1210.
    >> Share

  169. MITA T, Osonoi Y, Someya Y, Osonoi T, et al
    Relationship of carbohydrate intake proportion to cardiovascular events in Japanese people with type 2 diabetes mellitus.
    J Clin Endocrinol Metab. 2025 Mar 21:dgaf179. doi: 10.1210.
    >> Share

  170. CHEN Z, Wu X, Yang Q, Zhao H, et al
    The Effect of SGLT2 Inhibition on Brain-related Phenotypes and Aging: A Drug Target Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2025;110:1096-1104.
    >> Share

  171. PETERS AL, Buzzetti R, Lee CJ, Pavo I, et al
    Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS.
    J Clin Endocrinol Metab. 2025;110:e962-e969.
    >> Share

  172. STEFANOVSKI D, Smiley DD, Punjabi NM, Umpierrez GE, et al
    Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test.
    J Clin Endocrinol Metab. 2025;110:e1108-e1115.
    >> Share

  173. LIU M, Gao M, Wu J, Zhu Z, et al
    Metabolic Syndrome and the Risk of Kidney Stones: Evidence from 487 860 UK Biobank Participants.
    J Clin Endocrinol Metab. 2025;110:e1211-e1219.
    >> Share


  174. Correction to: "Approach to Lipid Management in the Patient With Diabetes".
    J Clin Endocrinol Metab. 2025 Mar 14:dgaf161. doi: 10.1210.
    >> Share

  175. HUANG H, Cai J, Hu H, Cai L, et al
    Degree of Joint Risk Factor Control and Incident Fracture Outcomes in Individuals with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 Mar 13:dgaf172. doi: 10.1210.
    >> Share

  176. KONDO T, Senokuchi T, Yano M, Takeda H, et al
    Benefits and Accuracy of Real-Time CGM in Children and Adolescents with Type 1 Diabetes Attending Summer Camp: 2nd year.
    J Clin Endocrinol Metab. 2025 Mar 12:dgaf160. doi: 10.1210.
    >> Share

  177. STROEBEL BM, Gadgil M, Lewis K, Longoria K, et al
    Body Composition Differentiates Prediabetes Phenotype Clusters in the Diabetes Prevention Program Study.
    J Clin Endocrinol Metab. 2025 Mar 11:dgaf163. doi: 10.1210.
    >> Share

  178. SOTO-MOTA A, Carrillo-Larco R, Gregg E, Rojas-Martinez R, et al
    Clinical Heterogeneity and Transitions of Obesity in Mexico. A Longitudinal Analysis of Multiple Representative National Surveys.
    J Clin Endocrinol Metab. 2025 Mar 11:dgaf158. doi: 10.1210.
    >> Share

  179. MULLER NZ, Muresan IM, Kunzi A, Borojevic ZZ, et al
    Antibodies are predictive for diagnosis of celiac disease in pediatric type 1 diabetes.
    J Clin Endocrinol Metab. 2025 Mar 8:dgaf146. doi: 10.1210.
    >> Share

  180. NIERVES LA, Lin TT, Moradian A, Shen Q, et al
    Biomarkers, Proteoforms, and Mass Spectrometry-based Assays for Diabetes Clinical Research.
    J Clin Endocrinol Metab. 2025 Mar 8:dgaf159. doi: 10.1210.
    >> Share


  181. Correction to: "Inflammation and Prediction of Death in Type 2 Diabetes. Evidence of an Intertwined Link With Tryptophan Metabolism".
    J Clin Endocrinol Metab. 2025 Mar 7:dgaf119. doi: 10.1210.
    >> Share

  182. MUIR CA, Wittert GA, Handelsman DJ
    Approach to the patient: Low testosterone concentrations in men with obesity.
    J Clin Endocrinol Metab. 2025 Mar 7:dgaf137. doi: 10.1210.
    >> Share

    February 2025
  183. HENSKE J, Turner LV, Riddell MC
    Approach to the Patient: Type 1 Diabetes Management with Exercise - Prepare, Perform, Stabilize, and Study.
    J Clin Endocrinol Metab. 2025 Feb 28:dgaf136. doi: 10.1210.
    >> Share

  184. KANINA A, Stener-Victorin E, Butwicka A, Oberg AS, et al
    Adverse cardiometabolic outcomes in men with sisters with polycystic ovary syndrome.
    J Clin Endocrinol Metab. 2025 Feb 27:dgaf121. doi: 10.1210.
    >> Share

  185. HATIPOGLU B, Pronovost PJ
    Role of Diabetes Self-management Education for Our Health Systems and Economy.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  186. FETZNER J, Rafi E
    Glycemic, Cardiorenal, and Weight Implications on Noninsulin Pharmacotherapy for the Management of Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  187. BLANCHETTE JE, Nally LM, Wentzell K, Hughes AS, et al
    Insights on Improving Health Insurance Literacy in Diabetes.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  188. RAFI E, Tranchito L, Hatipoglu B
    Navigating Insulin Options for Diabetes Management.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  189. BASKIN RG, Karp KA
    Navigating the Spectrum of 4 Evidence-Based Nutrition Options for Type 2 Diabetes Management.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  190. TENREIRO K, Hatipoglu B
    Mind Matters: Mental Health and Diabetes Management.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  191. BLANCHETTE JE, Paquin F, Dobbs BN, Kiely RL, et al
    Incorporating Complementary Therapies Into Diabetes Care.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  192. HATIPOGLU B
    Editorial: A Guidebook for Providers on Comprehensive Diabetes Care.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  193. LUNDGRIN EL, Hatipoglu B
    Trending Modalities in Type 2 Diabetes Prevention.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  194. TSUSHIMA Y, Galloway N
    Glycemic Targets and Prevention of Complications.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  195. LUNDGRIN EL, Kelly CA, Bellini N, Lewis C, et al
    Diabetes Technology Trends: A Review of the Latest Innovations.
    J Clin Endocrinol Metab. 2025;110.
    >> Share

  196. HSIAO YY, Chen YY, Kuo MJ, Chien YS, et al
    SGLT2i and Cardiovascular Events in Patients With Concomitant Atrial Fibrillation and Diabetes: A TriNetX Cohort Study.
    J Clin Endocrinol Metab. 2025 Feb 25:dgae861. doi: 10.1210.
    >> Share

  197. GALDERISI A, Bonet J, Ismail HM, Moran A, et al
    Metabolic phenotype of Stage 1 and Stage 2 type 1 diabetes using modelling of beta cell function.
    J Clin Endocrinol Metab. 2025 Feb 24:dgaf086. doi: 10.1210.
    >> Share

  198. NAKAMURA T, Tsujimoto T, Yasuda K, Kajio H, et al
    Consistently low serum levels of MG-H1 is associated with a lower risk of diabetic kidney disease.
    J Clin Endocrinol Metab. 2025 Feb 22:dgaf098. doi: 10.1210.
    >> Share

  199. BUROKAS A, Mela V
    Cognitive risk stratification in type 2 diabetes: a step toward early detection.
    J Clin Endocrinol Metab. 2025 Feb 19:dgaf105. doi: 10.1210.
    >> Share

  200. WEN Z, Liu X, Liu H
    Letter to the Editor from [Wen et al.]: "[Glycaemic control and adult height: a nationwide Swedish cohort study on childhood type 1 diabetes].".
    J Clin Endocrinol Metab. 2025 Feb 18:dgaf091. doi: 10.1210.
    >> Share

  201. NOMOTO H, Furusawa S, Yokoyama H, Suzuki Y, et al
    Improvement of beta-Cell Function After Switching From DPP-4 Inhibitors to Oral Semaglutide: SWITCH-SEMA2 Post Hoc Analysis.
    J Clin Endocrinol Metab. 2025;110:e583-e591.
    >> Share

  202. LIU S, Wan H, Nie S, Cao H, et al
    Dipeptidyl Peptidase 4 Inhibitors vs Metformin for New-onset Dementia: A Propensity Score-matched Cohort Study.
    J Clin Endocrinol Metab. 2025;110:e650-e659.
    >> Share

  203. GURUNG RL, Zheng H, Tan JLI, Liu S, et al
    Plasma proteins predict kidney function trajectories in type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Feb 14:dgaf095. doi: 10.1210.
    >> Share

  204. ANDERSSON M, Agren A, Henriksson P, Wallen H, et al
    Influence of bariatric surgery on endothelial and glycocalyx biomarkers in obesity and type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Feb 13:dgaf092. doi: 10.1210.
    >> Share

  205. WITTERT GA, Robledo KP, Handelsman DJ, Inder WJ, et al
    Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) Trial.
    J Clin Endocrinol Metab. 2025 Feb 10:dgaf060. doi: 10.1210.
    >> Share

  206. OLSEN MT, Liarakos AL, Wilmot EG, Dhatariya K, et al
    Implementation strategies for inpatient continuous glucose monitoring-based diabetes management: a systematic review.
    J Clin Endocrinol Metab. 2025 Feb 7:dgaf074. doi: 10.1210.
    >> Share

  207. BOLIER M, de Winter DTC, Fiocco M, van den Berg SAA, et al
    Prevalence and determinants of diabetes mellitus in 2,338 long-term Dutch childhood cancer survivors (DCCS-LATER2 Study).
    J Clin Endocrinol Metab. 2025 Feb 7:dgaf078. doi: 10.1210.
    >> Share

  208. UNNI US, Bril F, Mugler JP 3rd, Carter RE, et al
    Role of Hepatic Glycogen on Nocturnal Gluconeogenesis in Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2025 Feb 4:dgaf044. doi: 10.1210.
    >> Share

  209. NOONAN SB, Brennecke SP, Jones GD
    Predicting Preeclampsia in Gestational Diabetes Mellitus using the sFlt-1/PlGF Ratio.
    J Clin Endocrinol Metab. 2025 Feb 4:dgaf069. doi: 10.1210.
    >> Share

  210. CAMOIN M, Mohammedi K, Saulnier PJ, Hadjadj S, et al
    Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population.
    J Clin Endocrinol Metab. 2025 Feb 4:dgae852. doi: 10.1210.
    >> Share

  211. ZHANG J, Tam WWS, Lu J, Chen J, et al
    Cognitive Risk Stratification Score in Middle-aged and Older Adults with Type 2 Diabetes: a Cross-Sectional Study.
    J Clin Endocrinol Metab. 2025 Feb 4:dgaf063. doi: 10.1210.
    >> Share

  212. HUANG X, Xu Q, Chen L, Liu L, et al
    Potential mechanism associated with post-heart transplantation diabetes mellitus in Chinese patients.
    J Clin Endocrinol Metab. 2025 Feb 1:dgaf071. doi: 10.1210.
    >> Share

    January 2025
  213. DIEDISHEIM M, Mallone R, Pugliese A, Dubois-Laforgue D, et al
    Insulitis and exocrinitis in autoantibody-positive non-diabetic individuals: role of HLA genotypes.
    J Clin Endocrinol Metab. 2025 Jan 28:dgaf039. doi: 10.1210.
    >> Share

  214. NISHIKAGE S, Hirota Y, Takayoshi T, Yoshimura K, et al
    Utility of the C-peptide/insulin molar ratio for distinguishing type A insulin resistance syndrome from type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Jan 28:dgaf043. doi: 10.1210.
    >> Share

  215. SASO-JIMENEZ L, Urrutia I, Calvo B, Bilbao JR, et al
    Searching for monogenic autoimmune etiology in patients with type 1 diabetes onset under 30 months of age.
    J Clin Endocrinol Metab. 2025 Jan 28:dgaf049. doi: 10.1210.
    >> Share

  216. FERRARI S, Betah D, Feldman RG, Langdahl BL, et al
    Romosozumab Improves Tissue Thickness-Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes.
    J Clin Endocrinol Metab. 2025 Jan 24:dgae862. doi: 10.1210.
    >> Share

  217. FISHER M, Smith G, Potter BK, Arbuckle TE, et al
    The Association between Pregnancy Complications and Long-Term Maternal Cardiometabolic Health in the MIREC Cohort Study.
    J Clin Endocrinol Metab. 2025 Jan 23:dgaf041. doi: 10.1210.
    >> Share

  218. LIANG Y, Lim CGY, Ritchie SC, Bertin N, et al
    Circulating proteomic profiles are associated with type 2 diabetes in Asian populations - a longitudinal study.
    J Clin Endocrinol Metab. 2025 Jan 22:dgaf045. doi: 10.1210.
    >> Share

  219. LEWIS C, Rafi E, Dobbs B, Barton T, et al
    Tailoring Exercise Prescription for Effective Diabetes Glucose Management.
    J Clin Endocrinol Metab. 2025 Jan 21:dgae908. doi: 10.1210.
    >> Share

  220. PAPADIMITRIOU DT
    Letter to the Editor From Papadimitriou: "Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes".
    J Clin Endocrinol Metab. 2025 Jan 21:dgaf029. doi: 10.1210.
    >> Share

  221. AHMED F, Hetty S, Laterveer R, Surucu EB, et al
    Altered expression of aromatase and estrogen receptors in adipose tissue from men with obesity or type 2 diabetes.
    J Clin Endocrinol Metab. 2025 Jan 21:dgaf038. doi: 10.1210.
    >> Share

  222. JENSEN NJ, Porse AJ, Wodschow HZ, Speyer H, et al
    Relation of Insulin Resistance to Brain Glucose Metabolism in Fasting and Hyperinsulinemic States: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2025;110:e525-e537.
    >> Share

  223. NEWELL-PRICE J, Drummond JB, Gurnell M, Levy M, et al
    Approach to the Patient With Suspected Hypotonic Polyuria.
    J Clin Endocrinol Metab. 2025;110:e506-e514.
    >> Share

  224. BATTILLO DJ, Remchak ME, Shah AM, Malin SK, et al
    Impact of Insulin-Induced Relative Hypoglycemia on Vascular Insulin Sensitivity and Central Hemodynamics in Prediabetes.
    J Clin Endocrinol Metab. 2025;110:e423-e431.
    >> Share

  225. MISKELLY MG, Berggren J, Svensson M, Koffert J, et al
    The Effects of Calorie Restriction and Bariatric Surgery on Circulating Proneurotensin Levels.
    J Clin Endocrinol Metab. 2025;110:e497-e505.
    >> Share

  226. SHE R, Suvitaival T, Andersen HU, Hommel E, et al
    Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls.
    J Clin Endocrinol Metab. 2025 Jan 20:dgaf030. doi: 10.1210.
    >> Share

  227. ABU IRSHEED G, Steffen A, Martyn-Nemeth P, Park M, et al
    Multidimensional Sleep Health, Glycemic Control, and Self-Reported Outcomes in Type 1 Diabetes: A Cross-Sectional Study.
    J Clin Endocrinol Metab. 2025 Jan 16:dgaf032. doi: 10.1210.
    >> Share

  228. JAHOOR F, Hsu JW, Keene KR, Peacock WF, et al
    Amino acids and CART distinguish A-beta+ Ketosis-Prone Diabetes from type 1 and type 2 diabetes during hyperglycemic crises.
    J Clin Endocrinol Metab. 2025 Jan 16:dgaf033. doi: 10.1210.
    >> Share

  229. AN J, Zhang S, Cheng X, Jia C, et al
    The Association between Serum Polychlorinated Biphenyls and Incident Cardiovascular Disease among Type 2 Diabetes.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf014. doi: 10.1210.
    >> Share

  230. GERA S, Rearson A, Baker G, Douvas JL, et al
    Changes in 90-Day Time in Range Among Youth with Type 1 Diabetes Initiating Different Automated Insulin Delivery Systems.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf006. doi: 10.1210.
    >> Share

  231. WANG S, Zhang Y, Balati A, Li B, et al
    Effect of Sodium-Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf016. doi: 10.1210.
    >> Share

  232. KIM S, Subramanian S
    Approach to Lipid Management in the Patient with Diabetes.
    J Clin Endocrinol Metab. 2025 Jan 11:dgaf018. doi: 10.1210.
    >> Share

  233. HAAS AV, Koefoed AW, Celli J, Bonyhay I, et al
    Effect of Hypoglycemia on QT Interval in Individuals with and without Type 2 Diabetes: A Randomized Crossover Trial.
    J Clin Endocrinol Metab. 2025 Jan 9:dgae919. doi: 10.1210.
    >> Share

  234. DICKENS LT, Gonzalez MG
    Approach to the Patient using Diabetes Technology in Pregnancy.
    J Clin Endocrinol Metab. 2025 Jan 7:dgae914. doi: 10.1210.
    >> Share

  235. AMENDOLARA R, D'Onofrio L, Sessa RL, Di Giulio S, et al
    IFN-alpha neutralizing antibodies distinguish LADA from early-onset type 1 diabetes.
    J Clin Endocrinol Metab. 2025 Jan 6:dgaf001. doi: 10.1210.
    >> Share

    December 2024
  236. YANG X, Peng J, Sun F, Wu P, et al
    Renal function and risk of gestational diabetes mellitus: the potential mediating role of carnitine metabolites.
    J Clin Endocrinol Metab. 2024 Dec 18:dgae881. doi: 10.1210.
    >> Share

  237. JALLEH RJ, Plummer MP, Marathe CS, Umapathysivam MM, et al
    Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.
    J Clin Endocrinol Metab. 2024;110:1-15.
    >> Share

  238. SCHAUER PR, Rothberg AE
    Point-Counterpoint Debate: Surgery vs. Medical Treatment for the Management of Obesity.
    J Clin Endocrinol Metab. 2024 Dec 18:dgae888. doi: 10.1210.
    >> Share

  239. BHATTACHARYA S, Nagendra L, Dutta D, Kamrul-Hasan ABM, et al
    Treatment Versus Observation in Early Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    J Clin Endocrinol Metab. 2024 Dec 17:dgae878. doi: 10.1210.
    >> Share

  240. BASKOY G, Peterson R, Kempenich J, Triplitt C, et al
    Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Type 2 Diabetes Patients: A Pilot Study.
    J Clin Endocrinol Metab. 2024 Dec 17:dgae872. doi: 10.1210.
    >> Share

  241. GENOSAR R, Coman MM, Herold KC
    Reversing diabetes with your own cells: Closer to the dream.
    J Clin Endocrinol Metab. 2024 Dec 13:dgae851. doi: 10.1210.
    >> Share

  242. YOSHIMURA K, Hirota Y, Saito S, Nishikage S, et al
    Prediction of insulin requirements by explainable machine learning for individuals with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Dec 11:dgae863. doi: 10.1210.
    >> Share

  243. YOUSIF MF, Dolak KD, Adhikari S, White PC, et al
    A nested case-control study of adverse outcomes in children with diabetic ketoacidosis.
    J Clin Endocrinol Metab. 2024 Dec 6:dgae848. doi: 10.1210.
    >> Share

  244. YUEN L, Wong V, Immanuel J, Hague WM, et al
    Ethnic Differences in Characteristics of Women Diagnosed with Early Gestational Diabetes: Findings from the TOBOGM Study.
    J Clin Endocrinol Metab. 2024 Dec 6:dgae838. doi: 10.1210.
    >> Share

  245. FRANKS PW, Rich SS, Linder B, Zaghloul NA, et al
    A Research Roadmap to Address the Heterogeneity of Diabetes and Advance Precision Medicine.
    J Clin Endocrinol Metab. 2024 Dec 6:dgae844. doi: 10.1210.
    >> Share

  246. LIN YK, Ye W, Hepworth E, Rickels MR, et al
    Impaired Awareness and Symptomatology of Hypoglycemia in Adults with Type 1 Diabetes using Continuous Glucose Monitoring.
    J Clin Endocrinol Metab. 2024 Dec 5:dgae846. doi: 10.1210.
    >> Share

    November 2024
  247. JIANG X, Zhu F, Graca G, Du X, et al
    Serum metabolomic profiling of incident type 2 diabetes mellitus in the Multi-Ethnic Study of Atherosclerosis and Rotterdam Study.
    J Clin Endocrinol Metab. 2024 Nov 20:dgae812. doi: 10.1210.
    >> Share

  248. SMEW AI, Lundholm C, Gong T, Lichtenstein P, et al
    Glycaemic control and adult height: a nationwide Swedish cohort study on childhood type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Nov 18:dgae809. doi: 10.1210.
    >> Share

  249. MATHER KJ, Mari A, Heise T, DeVries JH, et al
    Effects of Tirzepatide vs Semaglutide on beta-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test.
    J Clin Endocrinol Metab. 2024;109:3046-3054.
    >> Share

  250. SIMONSON DC, Testa MA, Ekholm E, Su M, et al
    Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine.
    J Clin Endocrinol Metab. 2024;109:e2261-e2272.
    >> Share

  251. YARDLEY JE, Li Z, Zaharieva DP, Riddell MC, et al
    Sex Differences in Glycemia and Self-Management Strategies for Exercise in an Active Adults Cohort with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Nov 14:dgae792. doi: 10.1210.
    >> Share

  252. CHANG LY, Liao HW, Chen JY, Wu VC, et al
    Enhanced Outcomes in Type 2 Diabetes Patients with Acute Kidney Disease Through Thiazolidinedione.
    J Clin Endocrinol Metab. 2024 Nov 13:dgae796. doi: 10.1210.
    >> Share

  253. PHAM UN, Pryke A, Baskerville T, Griffin A, et al
    Kidney hyperfiltration and mitochondrial changes are associated with eGFR decline in young people with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Nov 11:dgae787. doi: 10.1210.
    >> Share

  254. WANG B, Dhaliwal R, Ewing SK, Schwartz AV, et al
    F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Nov 8:dgae788. doi: 10.1210.
    >> Share

  255. FENG Y, Shang B, Yang Y, Zhang D, et al
    Impact of DPP-4 inhibitors on interleukin levels in type 2 diabetes mellitus.
    J Clin Endocrinol Metab. 2024 Nov 8:dgae783. doi: 10.1210.
    >> Share

  256. ZHOU Q, Samadli S, Zhang H, Zheng X, et al
    Molecular and clinical profiles of pediatric monogenic diabetes subtypes: comprehensive genetic analysis of 138 patients.
    J Clin Endocrinol Metab. 2024 Nov 6:dgae779. doi: 10.1210.
    >> Share

  257. ALARCON G, Nguyen A, Jones A, Shields B, et al
    The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth.
    J Clin Endocrinol Metab. 2024 Nov 4:dgae770. doi: 10.1210.
    >> Share

  258. KAJITANI N, Umakoshi H, Kajitani Y, Kaneko H, et al
    Relationship between extracellular water to total body water ratio and severe diabetic retinopathy in type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Nov 1:dgae768. doi: 10.1210.
    >> Share

    October 2024
  259. BOUGHANEM H, de Larriva APA, Camargo A, Torres-Pena JD, et al
    Decreased neutrophils are associated with reduced risk of Type 2 Diabetes Incidence: Results from the CORDIOPREV study.
    J Clin Endocrinol Metab. 2024 Oct 29:dgae736. doi: 10.1210.
    >> Share

  260. GONG Y, Wang Q, Chen S, Liu Y, et al
    Heterogeneity of gestational diabetes and risk for adverse pregnancy outcome: a cohort study.
    J Clin Endocrinol Metab. 2024 Oct 24:dgae754. doi: 10.1210.
    >> Share

  261. SHEHADEH N, Galassetti P, Iqbal N, Karlsson C, et al
    Safety, Growth and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up).
    J Clin Endocrinol Metab. 2024 Oct 24:dgae723. doi: 10.1210.
    >> Share

  262. GOWER BA, Goss AM, Yurchishin ML, Deemer SE, et al
    Effects of a Carbohydrate-Restricted Diet on beta-Cell Response in Adults With Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Oct 22:dgae670. doi: 10.1210.
    >> Share

  263. JOHNSON RJ, Bergford S, Gal RL, Calhoun P, et al
    The Role of Whole Food Plant-Based Food Intake on Postprandial Glycemia in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Oct 18:dgae725. doi: 10.1210.
    >> Share

  264. BHAT SZ, Wu J, Perin J, Wang K, et al
    Effectiveness of Dexamethasone for COVID-19 in Hospitalized Patients with Diabetes: A Retrospective Cohort Study.
    J Clin Endocrinol Metab. 2024 Oct 17:dgae734. doi: 10.1210.
    >> Share

  265. HUBER E, Singh T, Bunk M, Hebel M, et al
    Discrimination and precision of Continuous Glucose Monitoring in staging children with presymptomatic type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Oct 16:dgae691. doi: 10.1210.
    >> Share


  266. Correction to: "The Association of Adiposity and RAAS With Incident Diabetes in African Americans: The Jackson Heart Study".
    J Clin Endocrinol Metab. 2024 Oct 16:dgae708. doi: 10.1210.
    >> Share

  267. SULEMAN S, Madsen AL, Angquist LH, Schubert M, et al
    Genetic Underpinnings of Fasting and Oral Glucose-stimulated Based Insulin Sensitivity Indices.
    J Clin Endocrinol Metab. 2024;109:2754-2763.
    >> Share

  268. KAMPMANN U, Suder LB, Nygaard M, Geiker NRW, et al
    Pre-pregnancy and gestational interventions to prevent childhood obesity.
    J Clin Endocrinol Metab. 2024 Oct 14:dgae724. doi: 10.1210.
    >> Share

  269. KELLY CA, Sipos JA
    Approach to the patient with thyroid nodules: considering GLP-1 receptor agonists.
    J Clin Endocrinol Metab. 2024 Oct 14:dgae722. doi: 10.1210.
    >> Share

  270. MCINTYRE H, Kampmann U, Dalsgaard Clausen T, Laurie J, et al
    Gestational diabetes: an update sixty years after O'Sullivan and Mahan.
    J Clin Endocrinol Metab. 2024 Oct 11:dgae709. doi: 10.1210.
    >> Share

  271. HSU JC, Yang YY, Chuang SL, Lin LY, et al
    Long-term Glycemic Variability Predicts Adverse Outcomes in Diabetic Heart Failure with Preserved Ejection Fraction.
    J Clin Endocrinol Metab. 2024 Oct 9:dgae715. doi: 10.1210.
    >> Share

  272. BROSSFIELD AV, McMahon DJ, Fernando J, Omeragic B, et al
    The Effects of the AGE Inhibitor Pyridoxamine on Bone in Older Women with Type 2 Diabetes: a Randomized Clinical Trial.
    J Clin Endocrinol Metab. 2024 Oct 8:dgae700. doi: 10.1210.
    >> Share

  273. PHAM-DOBOR G, Kaltenecker P, Temesfoi V, Bajnok L, et al
    Systematic analysis and network mapping of disease associations in autoimmune polyglandular syndrome.
    J Clin Endocrinol Metab. 2024 Oct 8:dgae701. doi: 10.1210.
    >> Share

  274. KEMPEGOWDA P, Castro-Revoredo I, Umpierrez GE
    Data-Driven Cluster Analysis Reveals Distinct Diabetes Subtypes in Black/African Americans in the United States.
    J Clin Endocrinol Metab. 2024 Oct 4:dgae680. doi: 10.1210.
    >> Share

  275. DUFT RG, Bonfante ILP, Palma-Duran SA, Chacon-Mikahil MPT, et al
    Response to Letter to the Editor from Chen and Shan: "Moderate-intensity Combined Training Induces Lipidomic Changes in Individuals with Obesity and Type 2 Diabetes".
    J Clin Endocrinol Metab. 2024 Oct 1:dgae685. doi: 10.1210.
    >> Share

  276. CHEN Q, Shan D
    Letter to the Editor from Chen and Shan: "Moderate-intensity Combined Training Induces Lipidomic Changes in Individuals with Obesity and Type 2 Diabetes".
    J Clin Endocrinol Metab. 2024 Oct 1:dgae684. doi: 10.1210.
    >> Share

    September 2024
  277. ECHOUFFO-TCHEUGUI JB, Dagogo-Jack S
    Aldosterone and Diabetes Risk: An Association in Need of Mechanistic Insights.
    J Clin Endocrinol Metab. 2024 Sep 23:dgae662. doi: 10.1210.
    >> Share

  278. LEBLANC E, Brooks N, Davies M, Chatterjee R, et al
    Sex-specific Cardiovascular Risk Factors and Treatment in Females with T2DM and CVD: Developments and Knowledge Gaps.
    J Clin Endocrinol Metab. 2024 Sep 23:dgae655. doi: 10.1210.
    >> Share

  279. WEBER DR, O'Brien KO, Ballester L, Rackovsky N, et al
    Greater urinary calcium excretion is associated with diminished bone accrual in youth with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Sep 20:dgae660. doi: 10.1210.
    >> Share

  280. CHANG L, Liu Y, Gu Y, Yan S, et al
    Inadequate Glucagon Suppression During OGTT in Prediabetes: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2024;109:2673-2680.
    >> Share

  281. DAGOGO-JACK S, Asuzu P, Wan J, Grambergs R, et al
    Plasma Ceramides and Other Sphingolipids in Relation to Incident Prediabetes in a Longitudinal Biracial Cohort.
    J Clin Endocrinol Metab. 2024;109:2530-2540.
    >> Share

  282. LEE MJ, Bae JH, Khang AR, Yi D, et al
    1-Hour Post-Load Glucose: Early Screening for High Risk of Type 2 Diabetes in Koreans with Normal Fasting Glucose.
    J Clin Endocrinol Metab. 2024 Sep 14:dgae632. doi: 10.1210.
    >> Share

  283. ELAM RE, Johnson KC, Xu H, Isales CM, et al
    Predictors of fracture in middle-aged and older adults with type 2 diabetes and overweight or obesity.
    J Clin Endocrinol Metab. 2024 Sep 11:dgae623. doi: 10.1210.
    >> Share

  284. SPARTANO NL, Sultana N, Lin H, Cheng H, et al
    Defining continuous glucose monitor time in range in a large community-based cohort without diabetes.
    J Clin Endocrinol Metab. 2024 Sep 11:dgae626. doi: 10.1210.
    >> Share

  285. SON J, Accili D
    Dedifferentiation as a stealthy disruptor of beta-cell function in diabetes.
    J Clin Endocrinol Metab. 2024 Sep 11:dgae624. doi: 10.1210.
    >> Share

  286. MITRO SD, Waetjen LE, Lee C, Wise LA, et al
    Diabetes and uterine fibroid diagnosis in midlife: Study of Women's Health Across the Nation (SWAN).
    J Clin Endocrinol Metab. 2024 Sep 11:dgae625. doi: 10.1210.
    >> Share

  287. WEBB-ROBERTSON BM, Wu W, Flores JE, Bramer LM, et al
    RNA Splicing Events in Circulation Distinguish Individuals with and without New-Onset Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Sep 10:dgae622. doi: 10.1210.
    >> Share

  288. PACCOU J
    Bone Microarchitecture in Older Men with Type 2 Diabetes: The Importance of Bone Size.
    J Clin Endocrinol Metab. 2024 Sep 6:dgae614. doi: 10.1210.
    >> Share

  289. KARAKUS KE, Fleury T, Baschal EE, McDaniel KA, et al
    Clinical Features and HLA Genetics Differ in Children at Type 1 Diabetes Onset by Hispanic Ethnicity.
    J Clin Endocrinol Metab. 2024 Sep 4:dgae608. doi: 10.1210.
    >> Share

  290. BENNETT WL, He JH, Michos ED, Kalyani RR, et al
    Weight Loss Differentially Impacts Sex Hormones in Women and Men with Type 2 Diabetes: Look AHEAD Sex Hormone Study.
    J Clin Endocrinol Metab. 2024 Sep 2:dgae584. doi: 10.1210.
    >> Share

    August 2024
  291. YANG C, Ji L, Han X
    Low C reactive protein-alleles in hepatocyte nuclear factor 1A are associated with an increased risk of cardiovascular disease: a Meta-analysis.
    J Clin Endocrinol Metab. 2024 Aug 30:dgae602. doi: 10.1210.
    >> Share

  292. MUCINSKI JM, Distefano G, Dube J, Toledo FGS, et al
    Insulin sensitivity and skeletal muscle mitochondrial respiration in Black and White women with obesity.
    J Clin Endocrinol Metab. 2024 Aug 29:dgae600. doi: 10.1210.
    >> Share

  293. MENZAGHI C, Marucci A, Mastroianno M, Di Ciaccia G, et al
    Inflammation and prediction of death in type 2 diabetes. Evidence of an intertwined link with tryptophan metabolism.
    J Clin Endocrinol Metab. 2024 Aug 28:dgae593. doi: 10.1210.
    >> Share

  294. KRAMER CK, Zinman B, Feig DS, Retnakaran R, et al
    The impact of time-restricted eating on beta-cell function in adults with type 2 diabetes: a randomized cross-over trial.
    J Clin Endocrinol Metab. 2024 Aug 28:dgae594. doi: 10.1210.
    >> Share

  295. TOPPARI J, Veijola R
    Symptomatic type 1 diabetes is approaching, but when?
    J Clin Endocrinol Metab. 2024 Aug 22:dgae578. doi: 10.1210.
    >> Share

  296. ROMERES D, Ruchi FNU, Breton MD, Basu A, et al
    Post Prandial Glucose Turnover Differs Between Adolescents & Adults with Type 1 Diabetes: Triple Tracer Mixed Meal Study.
    J Clin Endocrinol Metab. 2024 Aug 22:dgae585. doi: 10.1210.
    >> Share

  297. HA J, Kim JY, Springer M, Chhabra A, et al
    A Mathematical Model-Derived Disposition Index Without Insulin Validated in Youth with Obesity.
    J Clin Endocrinol Metab. 2024 Aug 22:dgae582. doi: 10.1210.
    >> Share

  298. CHENG W, Geng S, Li Y, Chen R, et al
    Sex Differences in 'Life's Essential 8' cardiovascular health and Type 2 Diabetes Mellitus Risk Across Menopause Stages.
    J Clin Endocrinol Metab. 2024 Aug 16:dgae557. doi: 10.1210.
    >> Share

  299. HAO L, Xue J
    Letter to the Editor from Hao and Xue: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy".
    J Clin Endocrinol Metab. 2024 Aug 16:dgae554. doi: 10.1210.
    >> Share

  300. GIONTELLA A, Akerlund M, Bronton K, Fava C, et al
    Deficiency of Peptidylglycine-alpha-amidating Monooxygenase, a Cause of Sarcopenic Diabetes Mellitus.
    J Clin Endocrinol Metab. 2024 Aug 13:dgae510. doi: 10.1210.
    >> Share

  301. LAMACCHIA O, Menzaghi C, Copetti M, Mastroianno M, et al
    GFR decline predicts total mortality and mediates the effect of tryptophan metabolism on death risk in type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Aug 13:dgae551. doi: 10.1210.
    >> Share

  302. WU L, Carlino MS, Brown DA, Long GV, et al
    Response to Letter to the Editor from Hao and Xue: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy".
    J Clin Endocrinol Metab. 2024 Aug 13:dgae555. doi: 10.1210.
    >> Share

  303. ERIKSEN R, White MC, Dawed AY, Perez IG, et al
    The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1: An IMI DIRECT Study.
    J Clin Endocrinol Metab. 2024;109:e1697-e1707.
    >> Share

  304. KAMIMOTO JLJ, Li Z, Gal RL, Castle JR, et al
    Effect of Impaired Awareness of Hypoglycemia on Glucose Decline During and After Exercise in the T1DEXI Study.
    J Clin Endocrinol Metab. 2024;109:2233-2241.
    >> Share

  305. ARMATO J, DeFronzo RA, Abdul-Ghani M, Ruby R, et al
    Pre-Prediabetes: Insulin Resistance is Associated with Cardiometabolic Risk in Non-obese Patients (STOP DIABETES).
    J Clin Endocrinol Metab. 2024 Aug 7:dgae540. doi: 10.1210.
    >> Share

  306. ABU IRSHEED G, Martyn-Nemeth P, Baron KG, Reutrakul S, et al
    Sleep disturbances in type 1 diabetes and mitigating cardiovascular risk.
    J Clin Endocrinol Metab. 2024 Aug 6:dgae539. doi: 10.1210.
    >> Share

  307. HE X, Cao L, Fu X, Wu Y, et al
    The association between telomere length and diabetes mellitus: accumulated evidence from observational studies.
    J Clin Endocrinol Metab. 2024 Aug 1:dgae536. doi: 10.1210.
    >> Share

  308. NI J, Su H, Wang Y, Lu W, et al
    Relationship between 1,5-anhydroglucitol and renal function assessed by dynamic renal scintigraphy in type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Aug 1:dgae509. doi: 10.1210.
    >> Share

    July 2024
  309. ISMAIL HM, Perera D, Mandal R, DiMeglio LA, et al
    Gut microbial changes associated with obesity in youth with type 1 diabetes: a Pilot Study.
    J Clin Endocrinol Metab. 2024 Jul 30:dgae529. doi: 10.1210.
    >> Share

  310. LU B, Li P, Crouse AB, Grimes T, et al
    Data-driven Cluster Analysis Reveals Increased Risk for Severe Insulin-Deficient Diabetes in Black/African Americans.
    J Clin Endocrinol Metab. 2024 Jul 30:dgae516. doi: 10.1210.
    >> Share

  311. WANG WJ, He H, Fang F, Liu X, et al
    Cord Blood Fetuin-B, Fetal Growth Factors and Lipids in Gestational Diabetes Mellitus.
    J Clin Endocrinol Metab. 2024 Jul 29:dgae520. doi: 10.1210.
    >> Share

  312. DUNNE F, Newman C, Alvarez-Iglesias A, O'Shea P, et al
    Postnatal Cardiometabolic Health After Metformin Use in Gestational Diabetes: A Secondary Analysis of the EMERGE Trial.
    J Clin Endocrinol Metab. 2024 Jul 26:dgae522. doi: 10.1210.
    >> Share

  313. SHEN I, Usala RL, Mohseni M, Bouxsein ML, et al
    Adolescent girls with type 1 diabetes develop changes in bone prior to evidence of clinical neuropathy.
    J Clin Endocrinol Metab. 2024 Jul 26:dgae511. doi: 10.1210.
    >> Share

  314. SONG DK, Oh J, Sung YA, Hong YS, et al
    All-cause mortality and incidence of cardiovascular diseases in lean patients with newly diagnosed type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Jul 26:dgae449. doi: 10.1210.
    >> Share

  315. SASIDHARAN PILLAI S, Gagnon CA, Foster C, Ashraf AP, et al
    Exploring the Gut Microbiota: Key Insights into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Jul 23:dgae499. doi: 10.1210.
    >> Share

  316. D'ADDIO F, Lazzaroni E, Lunati ME, Preziosi G, et al
    Vaccinome landscape in nearly 620,000 patients with diabetes.
    J Clin Endocrinol Metab. 2024 Jul 23:dgae476. doi: 10.1210.
    >> Share

  317. JIA X, Lin H, Ding Y, Gu X, et al
    Serum Medium-Chain Fatty Acids and the Risk of Incident Diabetes: Findings from the 4C Study.
    J Clin Endocrinol Metab. 2024 Jul 20:dgae483. doi: 10.1210.
    >> Share

  318. YOUSIF MF, Dolak KD, Adhikari S, White PC, et al
    Risk factors for adverse outcomes in children with diabetic ketoacidosis.
    J Clin Endocrinol Metab. 2024 Jul 20:dgae500. doi: 10.1210.
    >> Share

  319. KANG M, Zhu C, Lai M, Weng J, et al
    Machine Learning-Based Prediction of Large-for-Gestational Age Infants in Mothers with Gestational Diabetes Mellitus.
    J Clin Endocrinol Metab. 2024 Jul 16:dgae475. doi: 10.1210.
    >> Share

  320. JONSDOTTIR B, Clasen JL, Vehik K, Lernmark A, et al
    Early appearance of thyroid autoimmunity in children followed from birth for type 1 diabetes risk.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae478. doi: 10.1210.
    >> Share

  321. TIAN S, Guo T, Qian F, Qiu Z, et al
    Fish Oil, Plasma n-3 PUFAs, and Risk of Macro- and Microvascular Complications among Individuals with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae482. doi: 10.1210.
    >> Share

  322. FARAJ M, Schwartz AV, Burghardt AJ, Black D, et al
    Risk Factors for Bone Microarchitecture Impairments in Older Men with Type 2 Diabetes - The MrOS Study.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae452. doi: 10.1210.
    >> Share

  323. SHAH VP, Nayfeh T, Alsawaf Y, Saadi S, et al
    A Systematic Review Supporting the Endocrine Society Clinical Practice Guidelines on Vitamin D.
    J Clin Endocrinol Metab. 2024;109:1961-1974.
    >> Share

  324. GROSSMANN M, Robledo KP, Daniel M, Handelsman DJ, et al
    Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled Trial.
    J Clin Endocrinol Metab. 2024;109:2019-2028.
    >> Share

  325. SIMS EK, Cuthbertson D, Jacobsen L, Ismail HM, et al
    Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals.
    J Clin Endocrinol Metab. 2024;109:2116-2123.
    >> Share

  326. CORDINER RLM, Bedair K, Mari A, Pearson E, et al
    Low-Dose Sulfonylurea Plus DPP4 Inhibitor Lower Blood Glucose and Enhance Beta-Cell Function Without Hypoglycemia.
    J Clin Endocrinol Metab. 2024;109:2106-2115.
    >> Share

  327. WANG HH, Lin SH, Hung SY, Chiou YY, et al
    Renal protective effect of metformin in type 2 diabetes patients.
    J Clin Endocrinol Metab. 2024 Jul 11:dgae477. doi: 10.1210.
    >> Share

  328. HENNEY AE, Gillespie CS, Lai JYM, Schofield P, et al
    Risk of type 2 diabetes, MASLD and cardiovascular disease in people living with polycystic ovary syndrome.
    J Clin Endocrinol Metab. 2024 Jul 11:dgae481. doi: 10.1210.
    >> Share

  329. ABU-NEJEM R, Hannon TS
    Insulin Dynamics and Pathophysiology in Youth-Onset Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Jul 4:dgae463. doi: 10.1210.
    >> Share

  330. CAMERON-PIMBLETT A, La Rosa C, Davies MC, Suntharalingham JP, et al
    Characterization of Turner Syndrome-associated diabetes mellitus.
    J Clin Endocrinol Metab. 2024 Jul 4:dgae357. doi: 10.1210.
    >> Share

  331. WANG W, Xiao W, Song Z, Zhuang Z, et al
    Fetal/maternal-determined birth weight and adulthood type 2 diabetes and its subtypes: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2024 Jul 4:dgae455. doi: 10.1210.
    >> Share

  332. HORMAZABAL-AGUAYO I, Huerta-Uribe N, Munoz-Pardeza J, Ezzatvar Y, et al
    Association of physical activity patterns with nocturnal hypoglycemia events in youth with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Jul 2:dgae451. doi: 10.1210.
    >> Share

    June 2024
  333. LETH-MOLLER M, Hulman A, Kampmann U, Hede S, et al
    Effect of gestational diabetes on fetal growth rate and later overweight in the offspring.
    J Clin Endocrinol Metab. 2024 Jun 25:dgae428. doi: 10.1210.
    >> Share

  334. LANKINEN MA, Nuotio P, Kauppinen S, Koivu N, et al
    Effects of genetic risk on incident type 2 diabetes and glycemia: the T2D-GENE lifestyle intervention trial.
    J Clin Endocrinol Metab. 2024 Jun 18:dgae422. doi: 10.1210.
    >> Share

  335. NEDUNGADI D, Adesanya TMA, Rayan MN, Zhao S, et al
    The Association of Adiposity and RAAS with Incident Diabetes in African Americans: The Jackson Heart Study.
    J Clin Endocrinol Metab. 2024 Jun 17:dgae396. doi: 10.1210.
    >> Share

  336. FRIAS JP, De Block C, Brown K, Wang H, et al
    Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2).
    J Clin Endocrinol Metab. 2024;109:1745-1753.
    >> Share

  337. DI FILIPPO L, Giustina A
    Vitamin D deficiency and type 2 diabetes: the dangerous link between two modern pandemics.
    J Clin Endocrinol Metab. 2024 Jun 13:dgae390. doi: 10.1210.
    >> Share

  338. CALVIGIONI M, Biancalana E, Mazzantini D, Celandroni F, et al
    In-depth microbiological characterization of urine from subjects with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Jun 13:dgae389. doi: 10.1210.
    >> Share

  339. KJAERGAARD AD, Ellervik C, Jessen N, Lessard SJ, et al
    Cardiorespiratory fitness, body composition, diabetes, and longevity: a two-sample Mendelian randomization study.
    J Clin Endocrinol Metab. 2024 Jun 12:dgae393. doi: 10.1210.
    >> Share

  340. VITALE RJ, Tinsley LJ, Volkening LK, Laffel LM, et al
    Lower Independent Self-Care Readiness Persists over Time in Teens with Type 1 Diabetes and Executive Function Challenges.
    J Clin Endocrinol Metab. 2024 Jun 12:dgae391. doi: 10.1210.
    >> Share

  341. LIU S, Tham WK, Lee J, Ang K, et al
    Plasma ceramides predict all-cause and cause-specific mortality in individuals with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Jun 8:dgae388. doi: 10.1210.
    >> Share

    May 2024
  342. MONTASER E, Farhy LS, Kovatchev BP
    Novel Detection and Progression Markers for Diabetes Based on Continuous Glucose Monitoring Data Dynamics.
    J Clin Endocrinol Metab. 2024 May 31:dgae379. doi: 10.1210.
    >> Share


  343. Correction to: "Moderate-intensity Combined Training Induces Lipidomic Changes in Individuals With Obesity and Type 2 Diabetes".
    J Clin Endocrinol Metab. 2024 May 31:dgae328. doi: 10.1210.
    >> Share

  344. REDLING D, Bialak S, El Ghormli L, Chernausek SD, et al
    Circulating MicroRNAs as Predictors of Beta Cell Function in Youth-Onset Type 2 Diabetes: The TODAY study.
    J Clin Endocrinol Metab. 2024 May 30:dgae376. doi: 10.1210.
    >> Share

  345. XIE C, Huang W, Rayner CK, Horowitz M, et al
    Letter to the Editor From Xie et al: "The 13C Glucose Breath Test Accurately Identifies Insulin Resistance in People With Type 1 Diabetes".
    J Clin Endocrinol Metab. 2024 May 27:dgae366. doi: 10.1210.
    >> Share


  346. Correction to: "Dose-dependent Association of Alcohol Consumption With Obesity and Type 2 Diabetes: Mendelian Randomization Analyses".
    J Clin Endocrinol Metab. 2024 May 23:dgae343. doi: 10.1210.
    >> Share

  347. TRIOLO TM, Parikh HM, Tosur M, Ferrat L, et al
    Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives.
    J Clin Endocrinol Metab. 2024 May 20:dgae349. doi: 10.1210.
    >> Share

  348. POKHAREL P, Blekkenhorst LC, Bondonno CP, Murray K, et al
    Associations of vegetable and potato intakes with markers of type 2 diabetes risk in the AusDiab cohort.
    J Clin Endocrinol Metab. 2024 May 15:dgae333. doi: 10.1210.
    >> Share

  349. LIU J, Ai C, Li Z, Huang X, et al
    Titration of sedentary behavior with varying physical activity levels reduces mortality in patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 May 13:dgae323. doi: 10.1210.
    >> Share


  350. Correction to: "Vitamin D Status, Vitamin D Receptor Polymorphisms, and Risk of Type 2 Diabetes: A Prospective Cohort Study".
    J Clin Endocrinol Metab. 2024 May 13:dgae321. doi: 10.1210.
    >> Share

  351. PRIBITZER S, O'Rourke C, Ylescupidez A, Smithmyer M, et al
    Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 May 7:dgae292. doi: 10.1210.
    >> Share

  352. DENG R, Chen W, Zhang Z, Zhang J, et al
    Association between visceral obesity index and diabetes: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2024 May 6:dgae303. doi: 10.1210.
    >> Share

  353. NICOLI CD, Long DL, Plante TB, Judd SE, et al
    N-Terminal Pro-B-Type Natriuretic Peptide and Risk for Diabetes Mellitus and Metabolic Syndrome.
    J Clin Endocrinol Metab. 2024 May 4:dgae301. doi: 10.1210.
    >> Share

  354. OKOSHI C, Kyozuka H, Fukuda T, Yasuda S, et al
    Risk of gestational diabetes in women with PCOS based on body mass index: The Japan Environment and Children's Study.
    J Clin Endocrinol Metab. 2024 May 4:dgae293. doi: 10.1210.
    >> Share

  355. SCAIRATI R, Auriemma RS, Di Meglio S, Del Vecchio G, et al
    Risk Assessment of Diabetes Mellitus during and after Pregnancy in Women with Prolactinomas.
    J Clin Endocrinol Metab. 2024 May 2:dgae289. doi: 10.1210.
    >> Share

    April 2024
  356. LING P, Yang D, Wang C, Zheng X, et al
    Basal Hyperglycemia Contributes More Than Fifty Percent to Time in Range in Pregnant Women with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 30:dgae291. doi: 10.1210.
    >> Share

  357. KAARNIRANTA K, Valtanen M, Keinanen-Kiukaanniemi S, Tuomilehto J, et al
    Long-term cumulative incidence of clinically diagnosed retinopathy in the Finnish Diabetes Prevention Study.
    J Clin Endocrinol Metab. 2024 Apr 25:dgae287. doi: 10.1210.
    >> Share

  358. HSU HY, Chern YJ, Hsu MS, Yeh TL, et al
    Colorectal Cancer and Subsequent Diabetes Risk: A Population-based Cohort Study in Taiwan.
    J Clin Endocrinol Metab. 2024 Apr 25:dgae257. doi: 10.1210.
    >> Share

  359. HAGELQVIST PG, Andersen A, Maytham K, Andreasen CR, et al
    Hemostatic Effects of Exercise-Related Hypoglycemia in Male Persons With Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 20:dgae278. doi: 10.1210.
    >> Share

  360. NERILD HH, Gilliam-Vigh H, Ellegaard AM, Forman JL, et al
    Expression of bile acid receptors and transporters along the intestine of patients with type 2 diabetes and controls.
    J Clin Endocrinol Metab. 2024 Apr 18:dgae261. doi: 10.1210.
    >> Share


  361. Correction to: "Differential Diagnosis of Post Pancreatitis Diabetes Mellitus Based on Pancreatic and Gut Hormone Characteristics".
    J Clin Endocrinol Metab. 2024 Apr 17:dgae232. doi: 10.1210.
    >> Share

  362. GURUNG RL, Zheng H, Koh HWL, Yiamunaa M, et al
    Plasma proteomics of diabetic kidney disease among Asians with younger-onset type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae266. doi: 10.1210.
    >> Share

  363. CHE J, He N, Kuang X, Zheng C, et al
    Dietary n-3 fatty acids intake and all-cause and cardiovascular mortality in patients with pre-diabetes and diabetes.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae265. doi: 10.1210.
    >> Share

  364. LIANG Q, Li M, Huang G, Li R, et al
    Genetic Susceptibility, Mendelian randomization and Nomogram Model Construction of Gestational Diabetes Mellitus.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae200. doi: 10.1210.
    >> Share

  365. DU X, Zhu Y, Lu W, Fu N, et al
    Regulation of the Function of T Follicular Helper Cells and B Cells in Type 1 Diabetes Mellitus by the OX40/OX40L Axis.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae248. doi: 10.1210.
    >> Share

  366. ZU P, Wang H, Zhang L, Bian H, et al
    Insulinemic and inflammatory dietary patterns show enhanced predictive potential for gestational diabetes mellitus risk.
    J Clin Endocrinol Metab. 2024 Apr 13:dgae238. doi: 10.1210.
    >> Share

  367. LIN X, Zhu K, Qiu Z, Li R, et al
    Associations Between Beverage Consumption and Risk of Microvascular Complications Among Individuals With Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 12:dgae242. doi: 10.1210.
    >> Share

  368. LI L, Ji W, Wang Z, Cheng Y, et al
    Air pollution and diabetes mellitus: Association and validation in a desert area in China.
    J Clin Endocrinol Metab. 2024 Apr 9:dgae219. doi: 10.1210.
    >> Share

  369. PIEMONTE E, Bruzzaniti S, Galgani M
    Type 2 Diabetes: Fighting Inflammation Fire of T lymphocytes with Magnesium.
    J Clin Endocrinol Metab. 2024 Apr 9:dgae231. doi: 10.1210.
    >> Share

  370. MOON S, Lee M, Lee JS, Lee J, et al
    Association between hypotension during pancreatectomy and development of postoperative diabetes.
    J Clin Endocrinol Metab. 2024 Apr 9:dgae227. doi: 10.1210.
    >> Share

  371. FU Y, Lu M, Zhang K, Sun Y, et al
    Vitamin D status, vitamin D receptor polymorphisms, and risk of type 2 diabetes: A prospective cohort study.
    J Clin Endocrinol Metab. 2024 Apr 4:dgae221. doi: 10.1210.
    >> Share

  372. WEN H, Niu X, Yu R, Zhao R, et al
    Association of Serum AGR With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes.
    J Clin Endocrinol Metab. 2024 Apr 4:dgae215. doi: 10.1210.
    >> Share

  373. PUDDU PE, Menotti A
    Diabetes duration and the reverse impact between cholesterol levels and risk among individuals with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Apr 3:dgae217. doi: 10.1210.
    >> Share

    March 2024
  374. SAEI GHARE NAZ M, Farhadi-Azar M, Noroozzadeh M, Farahmand M, et al
    Follicle-Stimulating Hormone and Diabetes in Postmenopausal Women: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2024 Mar 30:dgae198. doi: 10.1210.
    >> Share

  375. SCHOWE AM, Czamara D, Lahti-Pulkkinen M, Girchenko P, et al
    Serial Diurnal Salivary Cortisol Profiles in 667 pregnant women - Association with Cardiometabolic Complications.
    J Clin Endocrinol Metab. 2024 Mar 29:dgae202. doi: 10.1210.
    >> Share

  376. LIU JJ, Liu S, Zheng H, Lee J, et al
    Urine tricarboxylic acid cycle metabolites and risk of end stage kidney disease in patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Mar 28:dgae199. doi: 10.1210.
    >> Share

  377. QIU Z, Lee DH, Lu Q, Li R, et al
    Associations of Regional Body Fat with Risk of Cardiovascular Disease and Mortality among Individuals with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Mar 26:dgae192. doi: 10.1210.
    >> Share


  378. Correction to: "Approach to the Patient With Type 2 Diabetes Requiring Add-On Medication".
    J Clin Endocrinol Metab. 2024 Mar 20:dgae160. doi: 10.1210.
    >> Share

  379. CIARDULLO S, Morabito G, Rea F, Savare L, et al
    Time trends in liver-related mortality in people with and without diabetes: Results from a population based study.
    J Clin Endocrinol Metab. 2024 Mar 20:dgae182. doi: 10.1210.
    >> Share

  380. KITAMURA T
    Useful biomarkers and clinical characteristics of post-pancreatitis diabetes mellitus (PPDM).
    J Clin Endocrinol Metab. 2024 Mar 19:dgae174. doi: 10.1210.
    >> Share

  381. DUFT RG, Bonfante ILP, Palma-Duran SA, Chacon-Mikahil MPT, et al
    Moderate-Intensity Combined Training Induces Lipidomic Changes in Individuals with Obesity and Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Mar 15:dgae177. doi: 10.1210.
    >> Share

  382. MERTENS J, Roosens L, Braspenning R, Vandebeeck J, et al
    The 13C glucose breath test accurately identifies insulin resistance in people with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Mar 15:dgae175. doi: 10.1210.
    >> Share

  383. FRITSCHE L, Loffler D, Kantartzis K, Flehmig G, et al
    Impact of breastfeeding duration on coagulation in women with and without history of gestational diabetes mellitus.
    J Clin Endocrinol Metab. 2024 Mar 15:dgae172. doi: 10.1210.
    >> Share

  384. SUPPLI MP, Hogedal A, Bagger JI, Chabanova E, et al
    Signs of Glucagon Resistance After a 2-Week Hypercaloric Diet Intervention.
    J Clin Endocrinol Metab. 2024;109:955-967.
    >> Share

  385. THORNTON PS, De Leon DD, Empting S, Zangen D, et al
    Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.
    J Clin Endocrinol Metab. 2024;109:1071-1079.
    >> Share


  386. Correction to: "Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement".
    J Clin Endocrinol Metab. 2024 Mar 14:dgae144. doi: 10.1210.
    >> Share

  387. WONG AYW, Hooi NMF, Yeo BSY, Sultana R, et al
    Improving Diabetic Wound Healing Outcomes with Topical Growth Factor Therapies: Systematic Review and Network Meta-analysis of Randomised-controlled Trials.
    J Clin Endocrinol Metab. 2024 Mar 13:dgae128. doi: 10.1210.
    >> Share

  388. SOOY MGQ, Pyle L, Alonso GT, Broncucia HC, et al
    Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia.
    J Clin Endocrinol Metab. 2024 Mar 12:dgae158. doi: 10.1210.
    >> Share

  389. CHAN YH, Chao TF, Chen SW, Lee HF, et al
    SGLT2 inhibitors vs. GLP-1 receptor agonists and clinical outcomes in patients with diabetes with/without atrial fibrillation.
    J Clin Endocrinol Metab. 2024 Mar 11:dgae157. doi: 10.1210.
    >> Share

  390. LIU W, Cai D, Zhang R, Zhang X, et al
    A randomized clinical trial for meal bolus decision using learning-based control in adults with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Mar 7:dgae143. doi: 10.1210.
    >> Share

  391. ALHENC-GELAS F, Marre M
    Young onset type2 diabetes: when gluconeogenesis is overfueled and out of control.
    J Clin Endocrinol Metab. 2024 Mar 5:dgae123. doi: 10.1210.
    >> Share

  392. BOURGONJE AR, Bourgonje MF, Sokooti S, la Bastide-van Gemert S, et al
    Plasma calprotectin and new-onset type 2 diabetes in the general population: a prospective cohort study.
    J Clin Endocrinol Metab. 2024 Mar 4:dgae130. doi: 10.1210.
    >> Share

  393. NIELSEN H, Windolf-Nielsen A, Scheuer SH, Damm P, et al
    Type 2 diabetes risk after gestational diabetes according to country/region of origin. A nationwide register-based study.
    J Clin Endocrinol Metab. 2024 Mar 1:dgae113. doi: 10.1210.
    >> Share

    February 2024
  394. LACLAUSTRA M, Alonso-Ventura V, Schipf S, Lou-Bonafonte JM, et al
    Higher Parametric Thyroid Feedback Quantile-based Index is a predictor of type 2 diabetes in a German population sample.
    J Clin Endocrinol Metab. 2024 Feb 29:dgae110. doi: 10.1210.
    >> Share

  395. CHEN GC, Hukportie DN, Liu YJ, Wang HP, et al
    Microvascular Disease, Cardiovascular Health, and Risk of Coronary Heart Disease in Type 2 Diabetes: A UK Biobank Study.
    J Clin Endocrinol Metab. 2024 Feb 27:dgae100. doi: 10.1210.
    >> Share

  396. CAI Y, Wei Q, Wang S, Lu X, et al
    All-Cause Mortality Differentials by Diabetes Status and Serum Neurofilament Light Chain Levels in U.S. General Adults.
    J Clin Endocrinol Metab. 2024 Feb 27:dgae102. doi: 10.1210.
    >> Share

  397. DRENTHEN LCA, Ajie M, de Baaij JHF, Tack CJ, et al
    Magnesium supplementation modulates T-cell function in people with type 2 diabetes and low serum magnesium levels.
    J Clin Endocrinol Metab. 2024 Feb 27:dgae097. doi: 10.1210.
    >> Share

  398. RAPINI N, Delvecchio M, Mucciolo M, Ruta R, et al
    The changing landscape of neonatal diabetes mellitus in Italy between 2003-2022.
    J Clin Endocrinol Metab. 2024 Feb 26:dgae095. doi: 10.1210.
    >> Share

  399. TRAMONTANA F, Napoli N, Litwack-Harrison S, Bauer DC, et al
    More rapid bone mineral density loss in older men with diabetes: The Osteoporotic Fractures in Men (MrOS) Study.
    J Clin Endocrinol Metab. 2024 Feb 26:dgae045. doi: 10.1210.
    >> Share

    December 2023
  400. RAZO-AZAMAR M, Nambo-Venegas R, Quevedo IR, Juarez-Luna G, et al
    Early pregnancy serum maternal and placenta-derived exosomes miRNAs vary based on pancreatic beta-cell function in GDM.
    J Clin Endocrinol Metab. 2023 Dec 21:dgad751. doi: 10.1210.
    >> Share

    November 2023
  401. STAMOU MI, Smith KT, Kim H, Balasubramanian R, et al
    Polycystic Ovarian Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci.
    J Clin Endocrinol Metab. 2023 Nov 15:dgad664. doi: 10.1210.
    >> Share

  402. ROCHA T, Melson E, Zamora J, Fernandez-Felix BM, et al
    Sex-Specific Obesity and Cardiometabolic Disease Risks in Low- and Middle-Income Countries: A Meta-Analysis Involving 3 916 276 Individuals.
    J Clin Endocrinol Metab. 2023 Nov 1:dgad599. doi: 10.1210.
    >> Share

    October 2023
  403. HIRSCHBERG AL
    Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What Is the Evidence?
    J Clin Endocrinol Metab. 2023 Oct 27:dgad590. doi: 10.1210.
    >> Share

    September 2023
  404. ANAWALT BD
    TRAVERSING the Mountain of Ignorance: Testosterone and Cardiovascular Safety.
    J Clin Endocrinol Metab. 2023 Sep 21:dgad555. doi: 10.1210.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016